CURRICULUM VITAE Suresh B. Boppana, M.D. University of … · 2019-05-21 · Suresh B. Boppana Page 4 . NIH • October 2017, NIDCD Institutional Research Training Grant Review (ZDC1

CURRICULUM VITAE

Suresh B. Boppana, M.D. University of Alabama at Birmingham

School of Medicine Faculty February 2019 PERSONAL INFORMATION Name: Suresh B. Boppana, M.D. Citizenship: Naturalized United States Citizen Foreign Languages: Telugu, Hindi Home Address: 2505 Crossgate Place Vestavia Hills, AL 35216 Home Phone: 205-979-2139 RANK/TITLE: Professor Primary Department: Pediatrics Division: Infectious Diseases Business Address: CHB 114, 1600 6th Avenue South

Birmingham, AL 35233 Phone: 205-996-7765 Fax: 205-975-6549 E-mail: [email protected] HOSPITAL AND OTHER (NON-ACADEMIC) APPOINTMENTS:

Year Title Institution 1990 – Present Active Staff Children’s of Alabama 1990 – Present Consulting Staff UAB Hospital 1989 – 1990

Attending Physician Allergy Clinic, San Francisco General Hospital, San Francisco, CA

1984 – 1985 Attending Physician Department of Pediatrics, Government General Hospital, Guntur, India

EDUCATION:

Year Degree Institution 1972 Government Junior College, Akunuru, India 1980 M.B.B.S. Guntur Medical College, Guntur, India 1984 M.D. Andhra Medical College, Visakhapatnam, India

MILITARY SERVICE: None LICENSURE:

• Alabama, #15386 1990 – Present • California, #A44871 1988 – Present • New Jersey, #48765 1986 – 1991 • Washington, #22421 1985 – 1988

mailto:[email protected]

Suresh B. Boppana Page 2 BOARD CERTIFICATION:

• American Board of Pediatrics , 1989, 1999, 2005, 2015 • American Board of Allergy and Immunology, 1993 • American Board of Pediatrics, Sub-Board of Pediatric Infectious Diseases, 1994, 2000,

2009 POSTDOCTORAL TRAINING:

Year Degree Institution Feb 1980 – Jan 1984 Pediatric Residency Andhra Medical College,

Visakhapatnam, India July 1985 – June 1987

Pediatric Residency Rutgers RWJ Medical School, New Brunswick, NJ

July 1987 – June 1988

Chief Resident, Pediatrics Rutgers RWJ Medical School, New Brunswick, NJ

July 1988 – June 1990

Fellow, Allergy/Immunology University of California, San Francisco

July 1990 – June 1993

Instructor/Fellow, Pediatric Infectious Diseases

UAB School of Medicine, Birmingham, AL

ACADEMIC APPOINTMENTS (In Reverse Chronological Order):

Year Rank/Title Institution 2017 – Hugh Dillon, M.D.

Endowed Professor in Pediatric Infectious Diseases

Department of Pediatrics, UAB School of Medicine, Birmingham, AL

2015 – 2017 Visiting Professor Department of Obstetrics & Gynecology, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA

2006 – Professor Department of Pediatrics, UAB School of Medicine, Birmingham, AL

2016 – Co-Medical Director Antimicrobial Stewardship Program, Children’s of Alabama

2004 –

Associate Scientist Minority Health and Research Center, UAB School of Medicine, Birmingham, AL

2000 – 2010 Director Pediatric Infectious Diseases Fellowship, UAB School of Medicine, Birmingham, AL

2000 – Associate Professor (Secondary Appt)

Department of Microbiology, UAB School of Medicine, Birmingham, AL

2000 – Scientist Comprehensive Cancer Center, UAB School of Medicine, Birmingham, AL

2000 – Scholar John J. Sparkman International Center for Global Health, UAB School of Medicine, Birmingham, AL

1999 – 2006

Associate Professor Department of Pediatrics, UAB School of Medicine, Birmingham, AL

1993 – 1999 Assistant Professor Department of Pediatrics, UAB School of Medicine, Birmingham, AL

1989 – 1990 Instructor Department of Pediatrics, University of California, San Francisco, CA

Suresh B. Boppana Page 3 1987 – 1988

Chief Resident UMDNJ-RWJ Medical School, New Brunswick, NJ

1984 – 1985 Assistant Professor Department of Pediatrics, Guntur Medical College, Guntur, India

AWARDS/HONORS:

• 1980, 2nd place, A.P. State Postgraduate Qualifying Examination • 1987 – 1988, Chief Resident, Department of Pediatrics, UMDNJ RWJ Medical School,

New Brunswick, NJ • 1988, Travel Grant, American College of Allergy and Immunology Annual Meeting, San

Antonio, TX. • 1989, American College of Allergy and Immunology/Norwich Eaton Research Award • 1991 – 1993, Bradford Dean Dixon Memorial Fellowship, Department of Pediatrics, UAB

School of Medicine, Birmingham, AL • 1991, Travel Award, 31st Interscience Conference on Antimicrobial Agents and

Chemotherapy Annual Meeting, Chicago, IL, September 29-October 2, 1991 • 1992, Travel Award, 32nd Interscience Conference on Antimicrobial Agents and

Chemotherapy Annual Meeting, Anaheim, CA, October 11-14, 1992 • 1992, Clinical Investigator Development Award, National Institute on Deafness and

Other Communication Disorders, NIH • 1994, Joyce Family Foundation Award for CMV Research • 1994 – 1996, Child Health Research Center Scholar, Department of Pediatrics, UAB

School of Medicine, Birmingham, AL • 1996, First Place, Oral Papers Session, First World Congress of Pediatric Infectious

Diseases, Acapulco, Mexico • 2002, Rud Polhill Research Award, The Research Institute at the Alabama Children’s

Hospital Foundation • 2005 – 2017, Selection by physician peers for inclusion in Best Doctors in America • 2009 – 2010, Department of Pediatrics Excellence in Teaching Award • 2010, Clinical Infectious Diseases Journal Award for Outstanding Review • 2015, Inaugural Congenital CMV Award, 5th International Congenital CMV Conference,

Brisbane, Australia, April 20-24, 2015 • 2017 – 2018 Department of Pediatrics Excellence in Teaching Award

PROFESSIONAL SOCIETIES/MEMBERSHIPS:

• Fellow, American Academy of Pediatrics (Elected) • Fellow, Infectious Diseases Society of America (Elected) • Fellow, Pediatric Infectious Diseases Society (Elected) • Member, American Pediatric Society (Elected) • Member, Society for Pediatric Research (Elected) • Member, AAP Section on Infectious Diseases • Member, American Society for Microbiology • Member, Southern Society of Pediatric Research • Member, European Society for Pediatric Infectious Diseases

COUNCILS AND COMMITTEES: NIH and Other Review Panels:

• June 2018, Neurological, Aging, and Musculoskeletal Epidemiology Study Section, CSR,

Suresh B. Boppana Page 4

NIH • October 2017, NIDCD Institutional Research Training Grant Review (ZDC1 SRB-X 69) • October 2016, Clinical Research and Field Studies of Infectious Diseases Study Section

(ZRG1 IDM-R 02), CSR, NIH • September 2016, NIDCD Institutional Research Training Grant Review (ZDC1 SRB-Y55) • October 2015, Member, Pediatrics Subcommittee (CHHD-A), NICHD, NIH • September 2015, Infections and Immunities Board (IIB) Scientific Review (QQR) of the

MRC University of Glasgow Centre for Virus Research (CVR) • April 2015, Member, Special Emphasis Panel (ZDC1 SRB-L (40)), Otitis Media Hearing

Clinical Trial Review, NIDCD, NIH • April 2015, Member, Special Emphasis Panel (ZDC SRB-K (19)), Review of Extramural

Loan Repayment Program Applications, NIDCD, NIH • February 2014, Member, Special Emphasis Panel (ZDC1 SRB-L (46), Otolaryngology

Clinical Trial Review, NIDCD, NIH • April 2013, Member, Special Emphasis Panel (ZDC1 SRB-R 32), Review of Extramural

Loan Repayment Program Applications, NIDCD, NIH • June 2012, Member, Communication Disorders Review Committee (CDRC), NIDCD,

NIH • November 2011, Member, R03 Hearing and Balance Review Panel (2012/01 ZDC1

SRB-L), NIDCD, NIH • February 2011, Member, Communication Disorders Review Committee (CDRC),

NIDCD, NIH • June 2010, Member, Member Conflict: Immunity, Host Defense, and Inflammation

Review Committee (ZRG1 IMM-E (02) M), NIAID, NIH • June 2010, Member, Communications Disorders Review Committee (CDRC), NIDCD,

NIH • June 2010, Member, Disease, Disability, and Injury Prevention Control Special

Emphasis Panel, CDC • April 2010, Member, Special Emphasis Panel (ZDC1 SRB-R 36-1), Review of

Extramural Loan Repayment Program Applications, NIDCD, NIH • October 2009, Member, Pediatrics Subcommittee (CHHD-A), NICHD, NIH • June 2009, Member, Communication Disorders Review Committee (CDRC), NIDCD,

NIH • May 2009, Reviewer, Office of Orphan Products Development Grant Program (ID2010),

FDA • April 2009, Member, Special Emphasis Panel, Review of Extramural Loan Repayment

Program Applications, NIDCD, NIH • October 2008, Member, Pediatrics Subcommittee (CHHD-A), NICHD, NIH • July 2008, CMV Panel Review, Centers for Disease Control and Prevention • March 2008, Member, Pediatrics Subcommittee (CHHD-A), NICHD, NIH • March 2007, Member, Hearing and Balance Review Panel (ZDC1 SRB-L 43), NIDCD,

NIH • October 2006, Member, Communication Disorders Review Committee Conflict

Committee, NIDCD, NIH (ZDC1 SRB-O 11) • April 2006, Member, Special Emphasis Panel (ZDC1 SRB-S(01), Review of Extramural

Loan Repayment Program Applications, NIDCD, NIH • January 2006, Chair, Middle Ear Pressure Regulation Clinical Center (P50) Review

Committee (ZDC1 SRB-R 32), NIDCD, NIH • November 2005, Member, Special Emphasis Panel/Scientific Review Group, Infectious

Diseases, Reproductive Health, Asthma, Pulmonary Epidemiology (ZRG1 IRAP-Q), NIH • May 2005, Member, Special Emphasis Panel (ZDC1 SRB-O), Review of Extramural


Loan Repayment Program Applications, NIDCD, NIH • February 2005, Chair, Middle Ear Clinical Center Review Committee (ZDC1 SRB-W45),

NIDCD, NIH • 2004 – 2008, Member, Communication Disorders Review Committee (CDRC), NIDCD,

NIH

National/International:

• Co-Chair, 7th International Congenital CMV Conference & 17th International CMV Workshop, Birmingham, AL, April 7-11, 2019

• Challenging Cases in Pediatric Infectious Diseases, Interactive Panelist, IDWeek 2017, San Diego, CA, October 4, 2017.

• 2017 – 2020, Member, PREP Infectious Disease Editorial Board • Advisory Committee, CMV Public Health and Policy Conference, Austin, TX, September

26-27, 2016 • National CMV Foundation – Member of the Board, 2015 - Present • Robin Cotton Panel -- Congenital CMV: Common but Not Commonly Recognized,

American Society of Pediatric Otolaryngology 2015 Spring Meeting, Boston, MA, April 26, 2015

• Inaugural Address, 5th International Congenital CMV Conference and 15th International CMV/Beta Herpesvirus Conference, Brisbane, Australia, April 20-24, 2015. Presentation: Global Burden of Congenital CMV Infection.

• Congenital CMV Consensus Recommendations Meeting on Diagnosis, Treatment and Prevention. Brisbane, Australia, April 19, 2015.

• Session Chair, Congenital CMV – Population Studies, 5thInternational Congenital Cytomegalovirus Conference and 15th International CMV/Beta Herpesvirus Conference, Brisbane, Australia. April 20-24, 2015.

• April 2015, Member, International Advisory Committee, 5thInternational Congenital Cytomegalovirus Conference and 15th International CMV/Beta Herpesvirus Conference, Brisbane, Australia

• December 2013, Abstracts Review Committee, 2014 Pediatric Academic Societies Annual Meeting

• December 2012, Abstracts Review Committee, 2013 Pediatric Academic Societies Annual Meeting

• 2012-2015, Member, Research Affairs Committee, Pediatric Infectious Diseases Society • August 2012, Reviewer, 2013 Pediatric Academic Societies Annual Meeting Workshop

Proposals • May 2012, UAB Healthcare Leadership Academy Class of 2012 • April 2012, Workshop Co-Leader, Congenital cytomegalovirus infection: Is it time for

universal newborn screening, Pediatric Academic Societies Annual Meeting, Boston, MA • February 2012, Abstracts Review Committee, European Society for Pediatric Infectious

Diseases Annual Meeting • January 2012, Chair, Session I: Background – Epidemiology and Diagnosis, The

Development and Evaluation of Human Cytomegalovirus Vaccines Workshop, Bethesda, MD

• January 2012, Member, Organizing Committee, The Development and Evaluation of Human Cytomegalovirus Vaccines Workshop, Bethesda, MD

• December, 2011, Abstracts Review Committee, 2012 Pediatric Academic Societies Annual Meeting

• September 2010, Session Co-Moderator, Neonatal Screening, 3rd Congenital Cytomegalovirus Conference, Paris, France.


• August 2010, Reviewer, 2011 Pediatric Academic Societies Annual Meeting Workshop Proposals

• September 2009, Member, CMV International Advisory Board, GSK Vaccines, Brussels, Belgium

• May 2009, Session Co-Moderator, Neonatal Infectious Diseases I: Immunology, Pediatric Academic Societies Annual Meeting, Baltimore, MD, May 2, 2009

• 2009, Subspecialty Abstracts Review Committee, 2010 Pediatric Academic Societies Annual Meeting

• February 2007, Member, Program Planning Committee, CASG Conference on Congenital Cytomegalovirus Infection, Bethesda, MD, February 21, 2007

• 2007, Subspecialty Abstract Review Committee, 2008 Pediatric Academic Societies Annual Meeting

• November 2006, Chair, Plenary Session II, 7th Asia Pacific Congress of Medical Virology, New Delhi, India, November 13, 2006

• November 2006, Member, International Advisory Committee, 7th Asia-Pacific Congress of Medical Virology, New Delhi, India

• November 2006, Indo-US Symposium in Advances in Viral Diagnostics – Epidemiology and Pathogenesis, New Delhi, India

• May 2005, Member, International Organizing Committee, 10th International Cytomegalovirus Workshop, Williamsburg, VA.

• May 2005, Chair, Congenital CMV and Hearing Deficit Session, 10th International Cytomegalovirus Workshop, Williamsburg, VA.

• January 2005, Abstract Reviewer, 2006 Pediatric Academic Societies Annual Meeting, Washington, DC

• 2001-2003, Member, International Affairs Committee, Pediatric Infectious Diseases Society

• March 2002, NIDCD/NIH Workshop: Congenital CMV Infection and Hearing Loss, Rockville, MD

• March 1997, Member, Local Organizing Committee, 6th International Cytomegalovirus Workshop, Orange Beach, AL.

• Ad hoc grant reviewer: Children’s Hospital Research Institute, Child Health Research Center at UAB, UAB Perinatal Health and Human Development Pilot Grant Program, University of South Dakota Research Foundation, Dixon Foundation, The Wellcome Trust, German Ministry of Education and Research

UNIVERSITY AND HOSPITAL ACTIVITIES:

• 2018 – Medical Coordinator, Alabama Department of Public Health TB Program • 2017 – Clinical Research/Patient Contact Committee, subcommittee of the UASOM

Space Utilization and Development • 2016 – Present, Medication Safety Committee, formal subcommittee of the Medical

Executive Committee of Children’s of Alabama, Birmingham, AL • 2015 – Present, Co-Director, Antimicrobial Stewardship Program, Children’s of Alabama • 2013 – 2015, Solutions for Patient Safety, Readmission HAC Team, Children’s of

Alabama • 2010, 2012 – 2015, Dixon Postdoctoral Fellowship Selection Committee, Department of

Pediatrics, UAB School of Medicine • 2009 – 2014, Member, Serious Event Council, The Children’s of Alabama • 2009 – 2011, Admissions Interview Committee, UAB School of Medicine • 2008 – 2015, Physicians Peer Review Committee, formal subcommittee of the Medical

Executive Committee of the Children’s of Alabama, Birmingham, AL


• 2005 – 2015, Department of Pediatrics Promotions and Review Committee, UAB School of Medicine, Birmingham, AL

• 2002 – 2006, Antimicrobial Subcommittee, Pharmacy and Therapeutics Committee, The Children’s of Alabama

• 2000 – 2010, Director, UAB Pediatric Infectious Disease Fellowship Training Program • 2000 – 2006, Admissions Interview Committee, UAB School of Medicine • 2000 – 2006, Residency Curriculum Committee, Department of Pediatrics, UAB School

of Medicine, Birmingham, AL • 2000 – 2004, Nutrition Subcommittee, Pharmacy and Therapeutics Committee, The

Children’s of Alabama EDITORIAL BOARD MEMBERSHIPS: Ad hoc reviewer

Acta Neuropathologica Communications, American Journal of Diseases in Children, American Journal of Obstetrics and Gynecology, Antiviral Research, Antiviral Therapy, Archives of Otolaryngology-Head & Neck Surgery, British Journal of Dermatology, Clinical Infectious Diseases, Clinical and Vaccine Immunology, European Journal of Clinical Microbiology & Infectious Diseases, European Journal of Pediatrics, Human Vaccines and Immunotherapeutics, Journal of the Association for Research in Otolaryngology, JAMA, Journal of Clinical Microbiology, Journal of Clinical Virology, Journal of Infectious Diseases, Journal of Pediatric Gastroenterology and Nutrition, Journal of Pediatrics, Journal of Pediatric Infectious Diseases Society, Journal of Perinatology, Journal of Pediatric Infectious Disease Society, Journal of Virology, Neonatology, PLoS Pathogens, Pediatric Infectious Disease Journal, Pediatric Research, Pediatric Transplantation, Pediatrics, Vaccine, Virology

MAJOR RESEARCH INTERESTS:

1) Pathogenesis of congenital CMV infection 2) Mechanisms of intrauterine transmission of CMV 3) CMV reinfections, strain variation and strain specific immunity 4) Identification of predictors of adverse outcome in congenital CMV infection 5) CMV-associated hearing loss

TEACHING EXPERIENCE:

• November 1996, UAB School of Public Health EPI 601 Vaccinology Course. Presentation: Viral Vaccine in Development

• October 1997, UAB School of Public Health EPI 601 Vaccinology Course. Presentation: New Childhood Vaccines

• October 1998, UAB School of Public Health EPI 601 Vaccinology Course. Presentation: Viral Vaccines in Development

• September 2001, UAB School of Public Health EPI 601 Vaccinology Course. Presentation: Varicella and Varicella Vaccines

• June 2002, Perinatal Viral Infections Workshop, University of Sao Paulo at Rebierao Preto, Brazil. Sparkman Center for International Public Health Education Training Grant Program: Presentations: CMV, HSV, VZV, Diagnosis of Perinatal Infections, and Quantitative PCR.

OTHER: Students, Postdoctoral Fellows and Trainees:


• Judson Miller, MD, Postdoctoral Fellow, Pediatric Infectious Diseases, 1994 – 1995 • Virginia G. James, Harvard University, Undergraduate Summer Research Trainee, 1999 • Lisa Rivera, Postdoctoral Trainee, Department of Health Care Organization and Policy,

UAB School of Public Health, 1999 – 2003 • Tiziana Lazorotto, MD, Visiting Postdoctoral Scientist, University of Bologna, Italy, 2000 • Zdenek Novak, MD, Postdoctoral Fellow, 2001 – 2006 • Shannon Ross, MD, Postdoctoral Fellow, Pediatric Infectious Diseases, 2003 – 2006 • Laurie Marzullo, MD, Postdoctoral Fellow, Pediatric Emergency Medicine, 2005 – 2006 • Guha Ashrith, MD, Postdoctoral Trainee, Department of Maternal and Child Health, UAB

School of Public Health, 2003 – 2004 • Haritha Vellanki, MD, Postdoctoral Trainee, Department of Epidemiology, UAB School of

Public Health, 2004 – 2005 • Rekha Kumbla, Vanderbilt University, Undergraduate Summer Research Trainee, 2003

– 2005 • Krati Chauhan, MD, Postdoctoral Trainee, Department of Maternal and Child Health,

UAB School of Public Health, 2005 – 2007 • Hari V. Gopal, MD, Postdoctoral Trainee, Department of Maternal and Child Health, UAB

School of Public Health, 2005 – 2007 • Glenn Bantug, Graduate Student, Department of Microbiology, UAB, Thesis Committee,

2005 – 2009 • Meera Reddy, Northwestern University, Undergraduate Summer Research Trainee,

2006 and 2007 • Nitin Arora, MD, Postdoctoral Trainee, Department of Maternal and Child Health, UAB

School of Public Health, 2006 – 2011 • Komal Shah, Alabama School of Fine Arts, Summer Research Trainee, 2007 • Sonia Singh, University of South Alabama School of Medicine, IDSA Medical Student

Summer Scholarship for Medical Students, 2007 • Renee Sullender, Homewood High School, Summer Research Trainee, 2009 • Sunil Pati, PhD, Postdoctoral Fellow, Pediatric Infectious Diseases, 2009 – 2013 • Smriti Krishnan, Hoover High School, Summer Research Trainee, 2010 and 2011 • Swetha Pinninti, MD, Postdoctoral Fellow, Pediatric Infectious Diseases, 2010 – 2013 • Varun Yerramsetti, Indian Springs High School, Summer Research Trainee, 2014 • Mackenzie Dreher, MD, Postdoctoral Fellow, Neonatology, 2011 – 2014 • Catherine Hough-Telford, MD, Postdoctoral Fellow, Pediatric Infectious Diseases, 2014

– 2016 • Noora Siddiqui, IDSA Medical Scholars Program, 2016 • Ravi Jariwala, IDSA Medical Scholars Program, 2016 • Anisha Khanijow, Russell Cunningham Memorial Research Program, Department of

Pediatrics, 2017 • Anisha Khanijow, IDSA Medical Scholars Program, 2017 • McKinley Williams, Undergraduate Research Training, UAB, 2019

MAJOR LECTURES AND VISITING PROFESSORSHIPS: • American College of Obstetricians and Gynecologists District II International Meeting,

Cancun, Mexico. Presentation: Cytomegalovirus. October 22, 1994 • UAB School of Medicine, Department of Pediatrics Grand Rounds. Presentation: CMV

Vaccines. June 20, 1996

Suresh B. Boppana Page 9 • Children’s Hospital of Los Angeles, Department of Infectious Diseases Noon Conference.

Presentation: Congenital Cytomegalovirus Infection. April 13, 1999 • University of Arizona, Department of Pediatrics Research Conference. Presentation:

Maternal Reinfection and Intrauterine Transmission of Cytomegalovirus. May 24, 1999 • Case Western Reserve University, Department of Pediatrics Research Conference.

Presentation: Congenital CMV Infection in Offspring of Immune Mothers. October 8, 1999 • J.J. Hospital, Mumbai, India. AIDS Research and Control Center Grand Rounds.

Presentation: Perinatal Transmission of HIV. December 14, 1999 • University of Tennessee, Department of Pediatrics Research Seminar. Presentation:

Congenital CMV infection: How protective is maternal CMV immunity? June 13, 2000 • Wake Forest University School of Medicine, Department of Pediatrics Research Seminar.

Presentation: Maternal Immunity and Congenital CMV Infection. August 23, 2000

• University of Kentucky School of Medicine, Department of Pediatrics Research Seminar. Presentation: Congenital CMV Infection in Offspring of Immune Mothers. September 22, 2000

• All India Institute of Medical Sciences, New Delhi, India, Department of Microbiology

Seminar. Presentation: Current update on Cytomegalovirus Disease of the Newborn. July 3, 2001

• Guntur Medical College, Guntur, India, Department of Pediatrics Grand Rounds.

Presentation: Prevention of Perinatal Transmission of HIV. July 16, 2001

• NIDCD/NIH Workshop: Congenital CMV Infection and Hearing Loss, Rockville, MD. Presentation: Implications of Mother-to-Fetus Transmission in Seronegative and Seropositive Mothers. March 19 - 20, 2002

• University of Sao Paulo at Rebierao Preto, Brazil, Perinatal Viral Infections Course.

Presentations: CMV, HSV, VZV, and Principles of Diagnosis of Perinatal Infections. June 17-21, 2002

• Children’s Hospital at Saint Peters University Hospital, New Brunswick, NJ, Department of

Pediatrics Grand Rounds. Presentation: Congenital CMV Infection, November 7, 2002

• UAB School of Public Health, Sparkman Seminar Series in Global Health. Presentation: Congenital Cytomegalovirus Infections in Highly Seroimmune Populations. February 17, 2003.

• Cincinnati Children’s Hospital Medical Center. Focus on Cytomegalovirus: Neonatal

Infection, Outcomes and Breast Milk Symposium. Presentation: Overview of Cytomegalovirus Infections in Infants. March 22, 2003.

• Saint Peters University Medical Center, New Brunswick, NJ. Department of Pediatrics Grand

Rounds. Presentation: Congenital CMV Infection and Hearing Loss. June 15, 2006 • UAB School of Medicine, Department of Pediatrics Grand Rounds. Presentation:


Congenital CMV Infection and Hearing Loss. January 5, 2006

• Indo-US Science and Technology Forum Symposium on Viral Diagnostics, Epidemiology and Pathogenesis, New Delhi, India. Presentation: Newer Concepts in Diagnosis of CMV Infections. November 11-12, 2006

• 7th Asia Pacific Congress of Medical Virology, New Delhi, India, November 13-15, 2006.

Presentation: Congenital CMV Infection in Highly Seropositive Population

• NIAID Collaborative Antiviral Study Group Conference on Congenital Cytomegalovirus, Bethesda, MD, February 21, 2007. Presentation: Epidemiology of Congenital CMV Infection

• Columbus Children’s Hospital, Columbus, OH, April 9, 2007. Presentation: CMV Strain

Variation and Reinfections: Implications for Vaccine Design

• Shriners Hospitals for Children – Northern California and Department of Pediatrics, University of California Davis, Sacramento, CA, December 13, 2007. Presentation: Congenital CMV Infection – Update

• 2008 Congenital Cytomegalovirus Conference, Atlanta, GA, November 5-7, 2008.

Presentation: Newborn Screening, Roundtable Presentation • GSK Vaccines International CMV Advisory Board Meeting, Brussels, Belgium, September

23-24, 2009. Presentation: CMV Burden and Potential Benefit of a Vaccine in Developing Countries

• Children’s Hospital of Buffalo, Neonatology Research Seminar. Presentation: Maternal

Immunity and Protection against Congenital CMV Infection. November 12, 2009

• Children’s Hospital of Buffalo, Pediatric Grand Rounds. Presentation: Congenital CMV Infection and Hearing Loss. November 13, 2009

• NIAID Collaborative Antiviral Study Group Surrogate Endpoint Workshop, Bethesda, MD,

February 17, 2010. Presentation: Congenital CMV Viral Load and Other Biomarkers: Challenges and Potential Possibilities.

• University of Illinois at Chicago School of Medicine, Department of Pediatrics Seminar.

Presentation: Congenital CMV Infection and Hearing Loss. April 7, 2010. • 3rd Congenital Cytomegalovirus Conference, Paris, France, September 25, 2010.

Presentation: Diagnostic tools for large-scale newborn screening. • All India Institute of Medical Sciences, New Delhi, India, Department of Microbiology

Seminar. Presentation: Congenital CMV Infection – An Update. March 4, 2011

• Centers for Disease Control and Prevention, Atlanta, GA. CDC CMV Awareness Day, June 20, 2011. Presentation: Newborn CMV screening.

• The Development and Evaluation of Human Cytomegalovirus Vaccines Workshop, Bethesda, MD. Presentation: Phase 3 Trial Design: Maternal, fetal and Newborn Endpoints. January 11, 2012.

Suresh B. Boppana Page 11 • PEDICON 2012, Gurgaon, India. IAP AAP Advanced CME. Presentation: When Bugs turn

Thugs….; Mechanisms of Drug Resistance Simplified. January 19, 2012.

• Fortis Hospital, Noida, India. Presentation: Antimicrobial Resistance. February 1, 2012.

• Pediatric Academic Annual Societies Meeting. Workshop: Congenital Cytomegalovirus (CMV) Infection: Is it Time for Universal Newborn Screening? Presentation: Screening tools for newborn screening. April 30, 2012

• 30th Annual Meeting of European Society of Pediatric Infectious Diseases, Thessaloniki, Greece. Presentation: Meet the Expert: Congenital CMV. May 10, 2012

• Workshop on Congenital Infections, Rijeka, Croatia. Presentation: Newborn CMV Screening. May 21, 2012

• International Consensus Meeting on Prevention and Therapy of Congenital Cytomegalovirus Infection, Rome, Italy. Presentation: Clinical Outcome. September 27, 2012

• ID Week 2012 Symposium, San Diego, CA. Cytomegalovirus Prevention and Management, Presentation: Postnatal Diagnosis of CMV. October 19, 2012

• 15th Annual Conference of the Infectious Diseases Chapter of the Indian Academy of Pediatrics (NCPID 2012), Nagpur, India. Presentation: Infections in Immunocompromised Host. November 24, 2012

• 15th Annual Conference of the Infectious Diseases Chapter of the Indian Academy of Pediatrics (NCPID 2012), Nagpur, India. Panel Discussion: Perinatal Viral Infections. November 25, 2012

• 29th Annual Clinical Virology Symposium and Annual Meeting of Pan American Society for Clinical Virology. Presentation: Congenital CMV Infection. April 29, 2013

• 16th Annual Conference of the Infectious Diseases Chapter of the Indian Academy of

Pediatrics (NCPID 2013), Vijayawada, India. Presentation: Emerging Infections: Rickessia/Brucellosis/Congo/Swine Flu, Member, Panel Discussion. December 21, 2013

• 16th Annual Conference of the Infectious Diseases Chapter of the Indian Academy of Pediatrics (NCPID 2013), Vijayawada, India. Presentation: Approach to a child with recurrent infections. Moderator, Panel Discussion. December 22, 2013

• 16th Annual Conference of the Infectious Diseases Chapter of the Indian Academy of Pediatrics (NCPID 2013), Vijayawada, India. Presentation: Approach to congenital infections. A workshop for post-graduate trainees. December 22, 2013

• UAB Schools of Dentistry, Medicine and Public Health, Program in Immunology.

Presentation: HCMV Reinfections—Failure of Immunity? April 10, 2014

• Rutgers Robert Wood Johnson Medical School, Department of Pediatrics Grand Rounds. Presentation: Congenital CMV infection. April 24, 2014

• ID Week 2014 Symposium, Philadelphia, PA. Cytomegalovirus Infection in Pregnant

Women, Neonates, and Immunocompromised: Common Problem with Not So Easy


Answers. Presentation: To Screen or Not to Screen: Should All Pregnant Women Be Screened for CMV. October 9, 2014.

• Pediatric Infectious Diseases Seminar, Children’s Hospital of Colorado and University of

Colorado, Denver, CO. Presentation: Maternal Immunity and Congenital CMV Infection. March 24, 2015.

• Congenital CMV Consensus Recommendations Meeting on Diagnosis, Treatment, and

Prevention, Brisbane, Australia, April 19, 2015.

• Inaugural Address: Global Burden of Congenital CMV Infection. 5thInternational Congenital Cytomegalovirus Conference and 15th International CMV/Beta Herpesvirus Conference, Brisbane, Australia, April 20, 2015.

• Robin Cotton Panel -- Congenital CMV: Common but Not Commonly Recognized, American

Society of Pediatric Otolaryngology 2015 Spring Meeting, Boston, MA, April 26, 2015.

• Michigan State University, East Lansing, MI. Research Seminar. Presentation: Maternal Immunity and Congenital CMV Infection. May 18, 2015.

• Helen DeVos Children’s Hospital, Grand Rapids, MI. Pediatric Grand Rounds. Presentation: Update on Congenital CMV Infection. May 19, 2015.

• Boston Children’s Hospital, Boston, MA. Department of Otolaryngology Research

Conference. Presentation: Congenital CMV Infection and Hearing loss. October 14, 2015.

• Mount Sinai School of Medicine, New York, NY. Infectious Diseases and Global and Emerging Pathogens Institute Seminar Series. Presentation: Maternal Immunity and Congenital CMV Infection – A Paradox. April 6, 2016.

• Nationwide Children’s Hospital, Columbus, OH. Clinical and Translational Seminar Series.

Presentation: Maternal Immunity and Congenital CMV Infection. April 26, 2016.

• CMV Public Health and Policy Conference, Austin, TX. Plenary Session, September 27, 2016. Presentation: cCMV positive, what is next? Are we prepared?

• Micro-S-Con 2016, Indian Association of Medical Microbiology Delhi Chapter Conference,

New Delhi, India. Advances in Viral Infections Symposium. November 18, 2016. Presentation: Congenital Viral Infections.

• Micro-S-Con 2016, Indian Association of Medical Microbiology Delhi Chapter Conference,

New Delhi, India. November 19, 2016. Presentation: Diagnosis of Viral Infections: an Enigma: ID perspective.

• 4th Annual Advances in Prenatal Molecular Diagnostics. Trends & Implications in a Rapidly

Changing Landscape. Cambridge, MA November 29, 2016. Presentation: Questions and Answers Related to Zika Virus Infection During Pregnancy.

• The Royal Society Theo Murphy International Scientific Meeting. Reducing Neonatal

Infectious Morbidity and Mortality: Joining up our thinking. The Royal Society at Chicheley Hall, Buckinghamshire, U.K. February 13-14, 2017. Presentation: Global Burden of Congenital CMV Infection.

Suresh B. Boppana Page 13 • Updates of Congenital and Neonatal Viral Infection. Pediatric Academic Societies Annual

Meeting, San Francisco, CA May 7, 2017. Presentation: Congenital Cytomegalovirus Infection.

• Saint Peters University Hospital, New Brunswick, NJ. Department of Pediatrics Grand

Rounds. Presentation: Congenital CMV Infection. November 16, 2017.

• Primary Children’s Hospital and The University of Utah, Salt Lake City, UT. Department of Pediatrics Grand Rounds. Presentation: Congenital CMV Infection. May 2, 2018.

• Chris Hani Baragwanath Hospital and Respiratory and Meningeal Pathogen Research Unit,

Soweto, South Africa. Pediatric Grand Rounds. Presentation: Global Burden of Congenital CMV Infection. July 25, 2018.

• Africa Health Research Institute and University of KwaZulu-Natal, Durban, South Africa.

Presentation; Predictors and Consequences of Congenital CMV Infection. July 30, 2008. CURRENT GRANT SUPPORT: 1R01AI109001 - 03A1 (Boppana) 09/01/14 – 08/31/18 1.80 calendar months NIH “Acquisition of HCMV from breast milk-correlates of protection” The goals of the project are to determine the quantity, specificity, and function of HCMV-specific antibodies in maternal breast milk and infant saliva, and the HCMV genome variability patterns associated with lower viral load and antiviral antibodies in these fluids and protection from HCMV breast milk transmission over the first 6 months after delivery. Role: PI 1 R21 HD083011-01 (Pillay) 05/20/15 – 02/28/19 (In no-cost extension) NIH “Congenital CMV infection in the era of Option B in South Africa” The goals of this study are to investigate the natural history and disease burden associated with congenital CMV infection in a high HIV burden setting. Role: Co-PI 1 R44DC016576 (Pamula) 08/01/17 – 07/31/19 0.60 calendar months NIH/NIDCD “Rapid, near patient nucleic acid testing for congenital cytomegalovirus (CMV) infection” The purpose of this study is to develop and validate diagnostic tests that are simple, reliable and can be adapted to widespread newborn screening for CMV infection. Role: Subcontract PI HHSN272201600017C (Kimberlin) 06/01/16 – 06/20/21 NIH/NIAID, “Targeted Clinical Research to Address Select Viral Infections” Role: Co-Investigator 1 R13 DC017912-01 (Boppana/Fowler/Ross) 02/18/19 – 02/1720 0.60 calendar months “International Congenital CMV Conference and CMV Workshop” Role: PI PENDING GRANT SUPPORT: 1 R01 AI139187-01A1 (Boppana/Sabbaj) 04/01/2019 – 03/31/24 2.4 calendar months “T cell responses and HCMV adaptation in Breast Milk Transmission” Role: PI

Suresh B. Boppana Page 14 PAST GRANT SUPPORT: UAB AMC21 – (Boppana) 04/01/16 –10 /31/18 “The role of T cell responses in controlling HCMV transmission via breast milk” Role: PI 1 K18 DC014289-01 (Boppana) 01/01/15 – 06/01/18 NIH “Genetic causes as co-factors in cytomegalovirus associated hearing loss” The objective of this NIDCD Research Career Enhancement Award (K18) application is to acquire advanced scientific knowledge and tools in the field of genetics and genomics, focusing on hearing loss in children. Role: PI 1 R01 DC012661-01 (Ross) 08/01/12 – 07/31/18 (In no-cost extension) NIH “Viral diversity in congenital cytomegalovirus infection” The purpose of this proposal is to define the diversity of CMV strains in all compartments of shedding in a large, well defined population of children with congenital CMV infection. We will also examine the effects of factors that alter viral replication; the immune response and antiviral therapy, on changes in viral populations over time. Role: Co-Investigator Cincinnati Children’s Hospital 10/15/15 – 4/14/18 NIH/NIAID “Vaccine and Treatment Evaluation Units (VTEU)” This subcontract will support analysis of samples from a CMV gB vaccine trial. This protocol will examine CMV genetic diversity in specimens (urine, saliva, plasma) from subjects with primary CMV infection. Role: Co-Investigator 2 R01 HD061959-07A2 (Britt) 09/15/11 – 06/30/17 NIH/NICHD “CMV vaccines: reinfection and antigenic variation” We propose to explore the amino acid sequence diversity of HCMV gN and its relationship to reinfection with new strains of HCMV. Role: Co-Investigator KPRI, Children’s of Alabama 02/01/16 – 01/31/18 Children’s of Alabama, “Vestibular function in children with congenital CMV infection” Role: Co-PI UAB AMC21 – (Britt) 06/01/15 – 05/31/17 “Congenital CMV infection in a highly seroimmune, urban maternal population” Our studies will define characteristics and mechanism leading to the increased incidence of congenital CMV infection in offspring in a population of urban women. Role: Co-Investigator HHS-N-263-2012-00010-C (Boppana) 06/12/12 – 06/12/15 NIH-NIDCD “The natural history of CMV-related hearing loss and the feasibility of CMV screening as an adjunct to hearing screening of the newborn – CHIMES follow-on” The overall objective of this proposal is to define the relative contribution of congenital cytomegalovirus (CMV) infection to permanent hearing impairment in children and to determine both the clinical validity and the utility of newborn CMV screening in the detection of

Suresh B. Boppana Page 15 sensorineural hearing loss (SNHL) in the newborn and in the prediction of SNHL in infancy and early years of life Role: PI 1 R44 DC012967-01 (Pamula) 12/01/12 – 07/31/15 NIH “Point-of-care nucleic acid test for cytomegalovirus for newborn hearing screening” The purpose of this study is to develop and validate diagnostic tests that are simple, reliable and can be adapted to widespread newborn screening for CMV infection. Role: Subcontract PI GlaxoSmithKline Biologicals 02/01/13 – 08/31/16 “A study in adolescent females to explore cytomegalovirus infection” This study is designed to estimate the incidence of CMV primary infections, reinfections and /or reactivations in adolescent females in order to determine the operational feasibility for future studies. Role: PI Kaul Pediatric Research Institute 01/01/11 – 12/31/12 “Mass spectrometry based approaches for newborn CMV screening” We propose to explore mass spectrometry based detection of CMV in newborn saliva specimens as an approach for large scale newborn CMV screening. Role: PI K23DC008539 (Ross) 12/01/06 -11/30/12 NIH-NIDCD “Viral determinants of cytomegalovirus related hearing loss” The goals of this project are to investigate the role of genetically unique strains of cytomegalovirus in the development of sensorineural hearing loss. Role: Co-Mentor 1 R03 HD061090-01 (Boppana) 09/15/09 – 08/31/12 NIH/NICHD “Congenital CMV infection and hearing loss in rural Indian population” We propose to test the hypothesis that a significant proportion of SNHL at birth or neonatal period in India is secondary to congenital CMV infection. Role: PI N01 DC50008 (Boppana) 07/01/05 – 06/30/12 NIH-NIDCD “The natural history of CMV-related hearing loss and the feasibility of CMV screening as an adjunct to hearing screening of the newborn” The overall objective of this proposal is to define the relative contribution of congenital cytomegalovirus (CMV) infection to permanent hearing impairment in children and to determine both the clinical validity and the utility of newborn CMV screening in the detection of sensorineural hearing loss (SNHL) in the newborn and in the prediction of SNHL in infancy and early years of life Role: PI UAB Center for AIDS Research 01/01/12 – 06/01/12 “Impact of maternal HIV infection on the prevalence and burden of congenital cytomegalovirus infection in a per-urban South African population” Stage I funding to identify and establish interdisciplinary collaborative network to formulate a research proposal.

Suresh B. Boppana Page 16 Role: PI CDC (Cannon) 03/01/09 – 09/30/09 National Vaccine Program Office “Phase II type-specific cytomegalovirus (CMV) antibody testing for previously collected samples” The broad objective of this proposal is to estimate the extent to which pre-existing immunity prevents reinfection with other strains of CMV and determine whether pre-existing immunity protects against CMV viremia during a reinfection or reactivation event using stored specimens from women enrolled in the HIV Epidemiology Research Study (HERS). Role: Co-PI 1 R03 TW006480 A1, (Britt) 04/01/04 – 03/31/07 NIH-NIAID “Congenital CMV in a Highly Seroimmune Maternal Population” The goals are to identify maternal risk factors associated with this high rate of congenital infection and to begin to define the relationship between viral genetic diversity and the high rate of congenital infection. Studies such as the one proposed in this application are particularly relevant to the development of strategies such as vaccination to limit this important cause of childhood disease. Role: Co-Investigator 1 R01 AI063565-01, (Pass) 09/01/04 – 08/31/08 NIH-NIAID "CMV Subunit Vaccine in Young Women at Risk" This clinical trial will test the efficacy of cytomegalovirus (CMV) glycoprotein B (gB) vaccine (Aventis Pasteur) with MF59 adjuvant (Chrion Vaccines) to prevent maternal CMV infection, using a phase II, randomized, placebo controlled, double-blind clinical trial. Role: Co-Investigator TRI (Boppana) 01/01/03 - 12/31/04 The Research Institute at the Children’s Hospital “Congenital CMV Infection: Dried Blood Spot PCR to Screen Newborns and to Predict Outcome” Role: PI P01 AI43681 (Britt) 10/01/98 - 09/30/03 NIH-NIAID “Project 2. Immunological Correlates of Vaccine-Induced Prevention of Congenital HCMV Infection” Role: Co-Investigator 1 R01 AI49537 (Britt) 03/01/02 - 02/28/09 NIH-NIAID “CMV Vaccines: Reinfection and Antigenic Variation” The major goal of this project is to characterize antigenic variation among CMV strains and the association between antigenic variation and CMV reinfection. Role: Co-Investigator R01 DC04163 (Boppana) 09/01/99 - 08/30/07 NIH-NIDCD “Congenital CMV Infection in Offspring of Immune Mothers”

Suresh B. Boppana Page 17 The major goal of this project is to define the mechanisms of intrauterine transmission of CMV in women who were seropositive before pregnancy. Role: PI TRI (Woolley) 01/01/99 - 12/31/00 The Research Institute of The Children’s Hospital “Mechanisms of CMV-Induced Hearing Loss in a Guinea Pig Model” Role: Co-Investigator TRI (Vaid) 01/01/97 - 12/31/98 The Research Institute of the Children's Hospital "Imaging of the Acoustic Pathway in Children with Congenital CMV Infection and Hearing Loss" Role: Co-Investigator

P01 AI43681 (Pass) 10/01/98 - 09/30/03 NIH-NIAID “Project 3. Mechanisms and Antiviral Therapy of Hearing Loss in Congenital CMV Infection” Role: Project Leader

P01 AI43681 (Britt) 10/01/98 - 09/30/04 NIH-NIAID “Laboratory Core for Program Project: Prevention of Maternal and Congenital CMV Infection” Role: Co-Investigator TRI (Boppana) 01/01/95 - 12/31/97 The Research Institute at the Children’s Hospital "Characterization of HCMV Specific Cytotoxic T-Cell Determinants" Role: PI R01 AI371975 (Sullender) 09/30/94 - 06/30/99 NIH-NIAID "RSV Vaccine Immunopotentiation: A Nonhuman Primate Model" Role: Co-Investigator 1 P30 HD28831 (Stagno) 09/01/94 - 08/31/96 NIH-NICHD, Child Health Research Center "Molecular Cell Biology in Pediatric Research" Role: Co-Investigator (Internal Award) P01 HD10699 (Pass) 07/20/93 - 06/30/99 NIH-NICHD “Outcome of Congenital CMV Infection” Role: Co-Investigator P01 HD10699 (Britt) 07/20/93 - 06/30/98 NIH-NICHD “Pathogenesis of Congenital HCMV Infections” Role: Co-Investigator K08 DC00079 (Boppana) 12/01/92 - 11/30/98 NIH-NIDCD "Pathogenesis of Hearing Loss in Congenital CMV Infection"

Suresh B. Boppana Page 18 Role: PI BIBLIOGRAPHY: Published Manuscripts: • Boppana SB, Frenkel LD. Thrombocytopenia in an HIV-seropositive infant. Ann Allergy

61:57, 1988. PMID:3389569

• Boppana SB, German DF, Frick OL. Chronic vulvovaginitis in a 30-year-old woman. Ann Allergy 66:381, 1991. PMID:2035900

• Boppana SB, Pass RF, Britt WJ, Stagno S, Alford CA. Symptomatic congenital

cytomegalovirus infection: neonatal morbidity and mortality. Pediatr Infect Dis J 11:93-99, 1992. PMID:1311066

• Boppana SB, Smith RJ, Stagno S, Britt WJ. Evaluation of a microtiter plate fluorescent-

antibody assay for rapid detection of human cytomegalovirus infection. J Clin Microbiol 30:721-723, 1992. PMID:1313050, PMCID:PMC265140

• Boppana SB, Pass RF, Britt WJ. Virus-specific antibody responses in mothers and their

newborn infants with asymptomatic congenital cytomegalovirus infections. J Infect Dis 167:72-77, 1993. PMID:8380292

• Boppana S, Amos C, Britt W, Stagno S, Alford C, Pass R. Late onset and reactivation of

chorioretinitis in children with congenital cytomegalovirus infection. Pediatr Infect Dis J 13:1139-1142, 1994. PMID: 7892084

• Boppana SB, Polis MA, Kramer AA, Britt WJ, Koenig S. Virus specific antibody responses

to human cytomegalovirus (HCMV) in human immunodeficiency virus type 1-infected individuals with HCMV retinitis. J Infect Dis 171:182-185, 1995. PMID:7798660

• Boppana SB, Britt WJ. Antiviral antibody responses and intrauterine transmission after

primary maternal cytomegalovirus infection. J Infect Dis 171:1115-1121, 1995. PMID:7751685

• Istas AS, Demmler GJ, Dobbins JG, Stewart JA, and the National Congenital

Cytomegalovirus Disease Registry Collaborating Group. Surveillance for congenital cytomegalovirus disease: a report from the National Congenital Cytomegalovirus Disease Registry. Clin Infect Dis 20:665-670, 1995. PMID: 7756493

• Anderson KS, Amos CS, Boppana S, Pass R. Ocular abnormalities in congenital

cytomegalovirus infection. J Am Optom Assoc 67:273-278, 1996. PMID:8888845

• Boppana SB, Britt WJ. Recognition of human cytomegalovirus gene products by HCMV-specific cytotoxic T cells. Virology 222:293-296, 1996 PMID: 8806513

• Boppana SB, Miller J, Britt WJ. Transplacentally acquired antiviral antibodies and outcome

in congenital human cytomegalovirus infection. Viral Immunol 9:211-218, 1996. PMID:8978017

• Fowler KB, McCollister FP, Dahle AJ, Boppana S, Britt WJ, Pass RF. Progressive and


fluctuating sensorineural hearing loss in children with asymptomatic congenital cytomegalovirus infection. J Pediatr 130:624-630, 1997. PMID:9108862

• Boppana SB, Fowler KB, Vaid Y, Hedlund G, Stagno S, Britt WJ, Pass RF.

Neuroradiographic findings in the newborn period and long-term outcome in children with symptomatic congenital cytomegalovirus infection. Pediatrics 99:409-414, 1997. PMID:9041297

• Fowler KN, Dahle AJ, Boppana SB, Pass RF. Newborn hearing screening: will children with hearing loss due to congenital cytomegalovirus infection be missed? J Pediatr 135:60-64, 1999. PMID: 10393605

• Boppana SB, Fowler KB, Britt WJ, Stagno S, Pass RF. Symptomatic congenital cytomegalovirus infection in infants born to mothers with preexisting immunity to cytomegalovirus. Pediatrics 104:55-60; 1999. PMID:10390260

• Pass FR, Duliege AM, Boppana S, Sekulovich R, Percell S, Britt W, Burke RL. A subunit cytomegalovirus vaccine based on recombinant envelope glycoprotein B and a new adjuvant. J Infect Dis 180:970-975, 1999. PMID:10479120

• Zanghellini F, Boppana SB, Emery VC, Griffiths PD, Pass RF. Asymptomatic primary cytomegalovirus infection: virologic and immunologic features. J Infect Dis 180:702-707, 1999. PMID:10438357

• Zhu Z, Atkinson TP, Hovanky KT, Boppana SB, Dai YL, Densen P, Go RC, Jablecki JS,

Volanakis JE. High prevalence of complement component C6 deficiency among African-Americans in the Southeastern United States. Clin Exp Immunol 119:305-310, 2000. PMID: 10632667, PMCID:PMC1905506

• Dahle AJ, Fowler KB, Wright JD, Boppana SB, Britt WJ, Pass RF. Longitudinal investigation

of hearing disorders in children with congenital cytomegalovirus infection. J Am Acad Audiol 11: 283-290, 2000. PMID:10821506

• Boppana SB, Rivera LB, Fowler KB, Mach M, Britt WJ. Intrauterine transmission of

cytomegalovirus to infants of women with preconceptional immunity. N Engl J Med 344: 1366-1371, 2001. PMID:11333993

• Rivera LB, Boppana SB, Fowler KB, Britt WJ, Stagno S, Pass RF. Predictors of hearing

loss in children with symptomatic congenital cytomegalovirus infection. Pediatrics 110: 762-767, 2002. PMID:12359792

• Bradford RD, Cloud G, Lakeman AD, Boppana S, Kimberlin DW, Jacobs R, Demmler G,

Sanchez P, Britt W, Soong S-J, Whitley RW and the National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Detection of cytomegalovirus (CMV) DNA by polymerase chain reaction is associated with hearing loss in newborns with symptomatic congenital CMV infection involving central nervous system. J Infect Dis 191:227-233, 2005. PMID:15609232

• Ross SA, Boppana SB. Congenital cytomegalovirus infection: outcome and diagnosis. Semin Pediatr Infect Dis 16:44-49, 2005. PMID:15685149

• Boppana SB, Fowler KB, Rivera LB, Pass RF, Bradford R, Lakeman F, Britt WJ.


Congenital cytomegalovirus infection: association between virus burden in infancy and hearing loss. J Pediatr 146:817-823, 2005. PMID:15973325

• Ross SA, Novak Z, Guha A, Rivera LB, Britt WJ, Hedges S, Schwebke JR, Boppana SB.

The association between genital tract cytomegalovirus infection and bacterial vaginosis. J Infect Dis 192:1727-30, 2005. PMID:16235170

• Fowler KB, Boppana SB. Congenital cytomegalovirus (CMV) infection and hearing deficit. J

Clin Virol 35:226-231, 2006. PMID:16386462 • Pass RF, Fowler KB, Boppana SB, Britt WJ, Stagno S. Congenital cytomegalovirus

infection following first trimester maternal infection: symptoms at birth and outcome. J Clin Virol 35:216-220, 2006. PMID: 16368262

• Ross SA, Fowler KB, Ashrith G, Stagno S, Britt WJ, Pass RF, Boppana SB. Hearing loss in

children with congenital cytomegalovirus infection born to mothers with preexisting immunity. J Pediatr 148:332-336, 2006. PMID:16615962

• Ross SA, Novak Z, Kumbla RA, Zhang K, Fowler KB, Boppana SB. GJB2 and GJB6

mutations in Cytomegalovirus related hearing loss. Pediatr Res 61:687-691, 2007. PMID:17426645

• Novak Z, Ross SA, Patro RK, Pati SK, Kumbla R, Brice S, Boppana SB. Cytomegalovirus strain diversity in seropositive women. J Clin Microbiol 46:882-886, 2008. PMID:18216215, PMCID:PMC2268346

• Dar L, Pati SK, Patro ARK, Deorari AK, Rai S, Kant S, Broor S, Fowler KB, Britt WJ, Boppana SB. Congenital cytomegalovirus infection in a highly seropositive semi-urban population in India. Pediatr Infect Dis J 27:841-843, 2008. PMID:18645544

• Novak Z, Ross SA, Patro RK, Pati SK, Reddy MK, Purser M, Britt WJ, Boppana SB. Enzyme-linked immunosorbent assay method for detection of cytomegalovirus strain-specific antibody responses. Clin Vaccine Immunol 16:288-290, 2009. PMCID:PMC2643547, PMID:19038783

• Rosenthal LS, Fowler KB, Boppana SB, Britt WJ, Pass RF, Schmid SD, Stagno S, Cannon MJ. Cytomegalovirus shedding and delayed sensorineural hearing loss: results from longitudinal follow-up of children with congenital infection. Pediatr Infect Dis J 28: 515-520, 2009. PMCID:PMC2757789, PMID:19483517

• Ross SA, Novak Z, Fowler KB, Arora N, Britt WJ, Boppana SB. Cytomegalovirus blood viral

load and hearing loss in young children with congenital infection. Pediatr Infect Dis J 28: 588-592, 2009. PMID: 19478688, PMCID:PMC3033214

• Mussi-Pinhata MM, Yamamoto AY, Britto RMM, Isaac ML, Boppana S, Britt WJ. Birth

prevalence and natural history of congenital cytomegalovirus (CMV) infection in a highly seroimmune population. Clin Infect Dis 49:522-8, 2009. PMCID:PMC2778219, PMID: 19583520

• Ross SA, Arora N, Novak Z, Fowler KB, Britt WJ, Boppana SB. Cytomegalovirus

reinfections in healthy seroimmune women. J Infect Dis 201:386-389, 2010. PMCID:PMC2804773, PMID: 20039807

Suresh B. Boppana Page 21 • Yamamoto AY, Mussi-Pinhata MM, Boppana SB, Novak Z, Wagatsuma VMD, Oliveira PF,

Duarte G, Britt WJ. Human cytomegalovirus reinfection is associated with intrauterine transmission in a highly CMV immune maternal population. Am J Obstet Gynecol 202 (3):297, 2010. PMID: 20060091, doi:10.1016/j.ajog.2009.11.018

• Boppana SB, Ross SA, Novak Z, Shimamura M, Tolan RW, Palmer AL, Ahmed A, Michaels MG, Sanchez PJ, Bernstein DI, Britt WJ, Fowler KB. Dried blood spot real-time polymerase chain reaction assays to screen newborns for congenital cytomegalovirus infection. JAMA 303 (14):1375-1382, 2010. PMCID:PMC2997517, PMID: 20388893

• Boppana SB, Fowler KB, Ross SA. Screening newborns for congenital cytomegalovirus infection—Reply. JAMA 304 (4):408, 2010

• Arora N, Novak Z, Fowler KB, Boppana SB, Ross SA. Cytomegalovirus viruria and

DNAemia in healthy seropositive women. J Infect Dis 202(12):1800-3, 2010. PMCID:PMC2988109, PMID: 21050121

• Atkinson TP, Boppana S, Theos A, Clements S, Li X, Waites K. Stevens-Johnson

syndrome in a patient with macrolide-resistant mycoplasma pneumoniae Pneumonia. Pediatrics, 127(6):e1605-9, 2011 [Epub May 2, 2011]. PMID:21536614 PMCID: N/A

• Boppana SB, Ross SA, Shimamura M, Palmer AL, Ahmed A, Michaels MG, Sanchez PJ,

Bernstein DI, Tolan RW, Novak Z, Chowdhury N, Britt WJ, Fowler KB. Saliva polymerase chain reaction assays for newborn cytomegalovirus screening. N Engl J Med 364:2111-2118, 2011. PMID:21631323, PMCID:PMC3153859

• Novak Z, Chowdhury N, Ross SA, Pati SK, Fowler KB, Boppana SB. Diagnostic consequences of cytomegalovirus glycoprotein B polymorphisms. J Clin Microbiol 49(8):3033-3035, 2011. PMID:21653769, PMCID:PMC3147759

• Ross SA, Novak Z, Pati S, Patro RK, Blumenthal J, Danthaluri VR, Ahmed A, Michaels MG,

Sánchez PJ, Bernstein DI, Tolan RW, Palmer AL, Britt WJ, Fowler KB, Boppana SB. Mixed infection and strain diversity in congenital cytomegalovirus infection. J Infect Dis 204(7):1003-1007, 2011 PMID: 21881114, PMCID:PMC3164425

• Yamamoto AY, Mussi-Pinhata MM, de Carvalho e Oliveira PF, Isaac MDL, Aragon DC, da Silva Manfredi AK, Boppana SB, Britt WJ. Congenital cytomegalovirus infection as a cause of sensorineural hearing loss in a highly immune population. Pediatr Infect Dis J 30(12):1043-1046, 2011. PMID: 21814153, PMCID:PMC3222783

• Ross SA, Novak Z, Pati SK, Boppana SB. Overview of the diagnosis of cytomegalovirus infection. Infect Disord Drug Targets 11:466-474, 2011. PMID: 21827433, PMCID:PMC3730495

• Pati SK, Novak Z, Purser M, Arora N, Mach M, Britt WJ, Boppana SB. Strain-specific neutralizing antibody responses against the human cytomegalovirus envelope glycoprotein N (gN). Clin Vaccine Immunol 19:909-913, 2012. PMID: 22492744, PMCID:PMC3370452

• Manicklal S, Lazzarotto T, Boppana SB, Emery VC, Gupta RK. The "silent" global burden of congenital cytomegalovirus. Clin Microbiol Rev 26(1):86-102, 2013. PMID: 23297260, PMCID:PMC3553672

http://dx.doi.org/10.1016/j.ajog.2009.11.018


• Pati SK, Pinninti SG, Novak Z, Chowdhury N, Patro R, Fowler K, Ross S, Boppana SB

for the NIDCD CHIMES study investigators. Genotypic diversity and mixed infection in newborn disease and hearing loss in congenital cytomegalovirus infection. Pediatr Infect Dis J 32:1050-1054, 2013. PMID: 23694837, PMCID:PMC: 3785554

• Krause PR, Bialek SR, Boppana SB, Griffiths PD, Laughlin CA, Ljungman P, Mocarski ES,

Pass RF, Read JS, Schleiss MR, Plotkin SA. Priorities for CMV vaccine development. Vaccine 32(1): 4-10, 2013. PMID: 24129123. PMCID: N/A

• Boppana SB, Ross SA, Fowler KB. Congenital cytomegalovirus infection: clinical outcome.

Clin Infect Dis 57 (suppl 4): S178-S181, 2013. PMID: 24257422. PMCID: N/A • Turner KM, Lee HC, Boppana SB, Carlo WA, Randolph DA. Incidence and impact of

cytomegalovirus infection in preterm infants. Pediatrics 133(3):e609-615, 2014. doi: 10.1542/peds.2013-2217. PMID:24488749, PMCID:PMC3934333.

• Dreher AM, Arora N, Fowler KB, Novak Z, Britt WJ, Boppana SB, Ross SA. Spectrum of disease and outcome in symptomatic congenital cytomegalovirus infection. J Pediatr 164(4):855-859, 2014. doi: 10.1016/j.jpeds.2013.12.007. PMID:24433826, PMCID:PMC: 3982912.

• Manicklal S, van Niekerk AM, Kroon SM, Hutto C, Novak Z, Pati SK, Chowdhury N, Hsiao N-Y, Boppana, SB. Birth prevalence of congenital CMV among infants of HIV-infected women on prenatal antiretroviral prophylaxis in South Africa. Clin Infect Dis 58 (10):1467-1472, 2014. doi: 10.1093/cid/ciu096. PMID:24567248. PMCID: N/A

• Ross SA, Ahmed A, Palmer A, Michaels M, Sanchez PJ, Bernstein DI, Tolan RW, Novak Z,

Chowdhury N, Fowler K, Boppana SB. Detection of congenital cytomegalovirus infection by real-time polymerase chain reaction of saliva or urine. J Infect Dis 210:1415-1418, 2014. doi: 10.1093/infdis/jiu263, PMID: 24799600, PMCID:PMC 4271051

• Olusanya BO, Slusher TM, Boppana SB. Prevalence of congenital cytomegalovirus

infection in Nigeria: a pilot study. Pediatr Infect Dis J 34(3):322-324, 2015. doi: 10.1097/INF.0000000000000555, PMID: 25742080, PMCID:PMC 4352715

• Pinninti SG, Shimamura M, Novak Z, Ross SA, Palmer AL, Ahmed A, Tolan RW, Bernstein

DI, Michaels MG, Sanchez PJ, Fowler KB, Boppana SB. Newborn CMV screening: Saliva PCR identifies more infants with congenital CMV infection than rapid culture. Pediatr Infect Dis J 34:536-7, 2015. Doi: 10.1097/INF.0000000000000609, PMID: 25876092, PMCID: PMC4400866

• Ross SA, Ahmed A, Palmer AL, Michaels MG, Sanchez PJ, Stewart A, Bernstein DI, Feja,

K, Novak Z, Chowdhury N, Fowler KB, Boppana SB for the National Institutes on Deafness and Other Communication Disorders CHIMES Study. Urine collection method for the diagnosis of congenital cytomegalovirus infection. Pediatr Infect Dis J 2015, 34(8): 903-905 doi: 10.1097/INF.0000000000000757 (Epub ahead of print, May 9, 2015)

• Pinninti SG, Rodgers MD, Novak Z, Britt WJ, Fowler KB, Britt WB, Boppana SB, Ross SA.

Clinical predictors of sensorineural hearing loss and neurodevelopmental outcome in children with symptomatic congenital cytomegalovirus infection. Pediatr Infect Dis J 35(8): 924-6, 2016 doi: 10.1097/INF.0000000000001194, PMID: 27195603

http://dx.doi.org/10.1093%2Finfdis%2Fjiu263


• Gantt S, Dionne F, Kozak FK, Goshen O, Goldfarb DM, Park AH, Boppana SB, Fowler K.

Cost-effectiveness of universal and targeted newborn screening for congenital cytomegalovirus infection. JAMA Pediatrics 1;170(12):1173-1180, 2016. (Published online October 10, 2016). PMID: 27723885

• Jariwala RH, Srialluri S, Huang MZ, Boppana SB. Methicillin-resistant Staphylococcus

areus as a cause of Lemierre’s syndrome. Pediatr Infect Dis J 36(4):429-431, 2017 (Published online December 12, 2016) PMID: 27977559

• Dar L, Namdeo D, Kumar P, Thakar A, Kant S, Rai S, Kabra M, Deorari A, Fowler KB,

Boppana SB. Congenital cytomegalovirus infection and permanent hearing loss in children in rural north India. Pediatr Infect Dis J, 36(7):670-673, 2017 (Published online, Dec 28, 2016). PMID: 28033238

• Fowler KB, McCollister FP, Sabo DL, Shoup AG, Owen KE, Woodruff JL, Cox E, Mohamed

LS, Choo DI, Boppana SB for the CHIMES study. A Targeted Approach for Congenital Cytomegalovirus (CMV) Screening within Newborn Hearing Screening. Pediatrics 139(2):e20162128, 2017, DOI: 10.1542/peds.2016-2128 (Published online January 3, 2017) PMID: 28049114

• Ross SA, Ahmed A, Palmer AL, Michaels MG, Sanchez PJ, Stewart A, Bernstein DI, Feja K,

Fowler KB, Boppana, SB. Newborn dried blood spot PCR to identify infants with congenital cytomegalovirus-associated sensorineural hearing loss. J Pediatr 184:57-61, 2017 (Published online February 22, 2017) PMID: 28237380

• Rawlinson W, Boppana SB, Fowler K, Kimberlin DW, Lazzarotto T, Alain S, Daly K, Doutré

S, Gibson L, Giles ML, Greenlee J, Hamilton S, Harrison GJ, Hui L, Jones CA, Palasanthiran P, Schleiss MR, Shand A, van Zuylen WJ. Congenital Cytomegalovirus Infection in Pregnancy and the Neonate: Consensus Recommendations for Prevention, Diagnosis, and Therapy. Lancet Infect Dis 17(6):e177-e188, 2017 (Published online March 10, 2017) PMID: 28291720

• Moylan DC, Pati SK, Ross SA, Fowler KB, Boppana SB, Sabbaj S. Breast milk HCMV viral

load drives the establishment of breast milk CMV-specific CD8 T cells in human CMV infected mothers. J Infect Dis 2017 Nov27; 216(9): 1176-1179. doi: 10.1093/infdis/jix457, PMID: 28968907.

• Fort P, Chang MR, Boppana S, David RO, Owen J, Carlo WA. Congenital cytomegalovirus

infection presenting with intrapulmonary calcifications on prenatal sonogram. Adv Pediatr Res 4:12; 2017.

• Boucoiran I, Mayer BT, Krantz EM, Pati S, Boppana S, Wald A, Corey L, Casper C, Schiffer

JT, Gantt, S. Maternal oral CMV recurrence following postnatal primary infection in infants. Pediatr Infect Dis J 37(7):627-31, 2018. doi: 10.1097.INF.0000000000001877. PMID: 29889809

• Ross SA, Michaels M, Ahmed A, Palmer A, Sanchez PJ, Bernstein DI, Feja K, Stewart A,

Boppana S, Fowler KB. Contribution of breastfeeding to false positive saliva PCR for newborn cytomegalovirus screening. J Infect Dis 217(10): 1612-15, 2018 (Published online February 1, 2018). doi: 10.1093/infdis/jiy057. PMID: 29401303

Suresh B. Boppana Page 24 • Barbosa NG, Yamamoto AY, Duarte G, Aragon DC, Boppana S, Fowler KB, Britt WJ, Mussi-

Pinhata MM. Cytomegalovirus (CMV) shedding in seropositive pregnant women from a high seroprevalence population: “The Brazilian Cytomegalovirus Hearing and Maternal Secondary Infection Study” (BraCHS). Clin Infect Dis 2018 (Published online February 27, 2018). doi: 10.1093/cid/ciy166. PMID: 29490030

• Puhakka L, Lappalainen M, Longnqvist T, Niermensivu R, Lindahl P, Nieminen T, Seuri R,

Nupponen I, Pati S, Boppana S, Saxen H. The burden of congenital cytomegalovirus infection: a prospective cohort study of 20,000 infants in Finland. J Pediatr Infect Dis Soc 2018 (Published online March 15, 2018). doi: 10.1093/jpids/piy027. PMID: 29554325

• Fowler KB, Ross SA, Shimamura M, Ahmed A, Palmer AL, Michaels MG, Bernstein DI,

Sanchez PJ, Feja K, Stewart A, Boppana SB. Racial and ethnic differences in the prevalence of congenital cytomegalovirus (CMV) infection. J Pediatr 2018 (Epub ahead of print May 18, 2018) PMID: 29784513, doi: 10.1016/j.jpeds.2018.04.043. PMID 29784513

• Gantt S, Marchant A, Boppana SB. Higher expectations for a vaccine to prevent congenital

cytomegalovirus infection. J Virol 92(15):e00764-18 (Letter To The Editor).

• Mussi-Pinhata MM, Yamamoto AY, Aragon DC, Duarte G, Fowler KB, Boppana S, Britt WJ. Seroconversion for cytomegalovirus infection during pregnancy and fetal infection in a highly seropositive population: “The BraCHS Study”. J Infect Dis 2018 (Epub ahead of print June 4, 2018). doi:10.1093.infdis/jiy321. PMID: 29868783

• Konduri A, Wolf A, Boppana SB. Invasive infections caused by Haemophilus influenzae

type A. Clinical Pediatrics, 2019 (Published online January 2) doi: 10.1177/0009922818821887.

• Pathirana J, Groome M, Dorfman J, Kwatra G, Boppana S, Cutland C, Jones S, Madhi SA.

Prevalence of congenital cytomegalovirus infection and associated risk of in-utero HIV acquisition in a high HIV prevalence setting, South Africa. Clin Infect Dis, 2019 (Epub ahead of print January 7). doi:10.1093/cid/ciz019.

• Yamamoto AY, Anastasio ART, Massuda ET, Isaac ML, da Silva Manfred AK, Cavalcante

JMS, Carevale da Silva A, Fowler KB, Boppana SB, Britt WJ, Mussi-Pinhata MM. Contribution of congenital cytomegalovirus (cCMV) to permanent hearing loss in a highly seropositive population: “The BraCHS Study”. Clin Infect Dis 2019 (In Press)

Submitted Manuscripts: • Dobson GC, Britt WJ, Fowler KB, Boppana SB, Ross SA. Next generation sequencing of

cytomegalovirus (CMV) genomes from congenitally infected infants in children with symptomatic infection and CMV-related hearing loss.

• Puhakka L, Lappalainen M, Longnqvist T, Niermensivu R, Lindahl P, Nieminen T, Seuri R, Nupponen I, Pati S, Boppana S, Saxen H. Viral shedding, and distribution of cytomegalovirus glycoprotein H (UL75), glycoprotein B (UL55), and glycoprotein N (UL73) genotypes in congenital cytomegalovirus infection

• Samies N, Jariwala R, Boppana S, Pinninti S. Utility of surface and blood polymerase chain

reaction (PCR) assays in identifying infants with neonatal herpes simplex virus (HSV) infection.

https://doi.org/10.1016/j.jpeds.2018.04.043

Suresh B. Boppana Page 25 Manuscripts in Preparation: • Characteristics of newborn disease in a large cohort of children with congenital CMV

infection identified on newborn CMV screening.

• Saliva viral load in infants with symptomatic congenital CMV infection and CMV-associated hearing loss at birth.

• Prevalence of congenital CMV infection and CMV-associated hearing loss at birth – Results of a multicenter newborn CMV screening study.

Invited Reviews and Textbook Chapters: • Pass RF, Fowler KB, Boppana S: Clinical importance of cytomegalovirus infection: an

overview. Excerpta Medica International Congress Series, Progress in Cytomegalovirus Research, 1991, pp 3-10

• Boppana SB, Britt WJ, Polis M, Koenig S. Antibody responses to human cytomegalovirus in HIV-1 seropositive patients with HCMV retinitis. In: Vaccines '92, Brown F, Chanock RM, Ginsberg HS, Lerner RA (eds), Cold Spring Harbor Laboratory Press (New York), 1992, pp 299-302

• Boppana SB. Cytokines in infectious diseases. Indian J Pediatr 63:447-452, 1996

• Boppana S, Pass RF: Cytomegalovirus. In: Viral Infections in Obstetrics and Gynecology,

Jeffries DJ, Hudson CN (eds), Chapman & Hall, London, 1999, pp 35-56

• Britt WJ, Boppana S. Human cytomegalovirus virion proteins. Hum Immunol 65(5): 395-402, 2004.

• Ross SA, Boppana SB. Congenital cytomegalovirus infection: outcome and diagnosis.

Semin Pediatr Infect Dis 16:44-49, 2005. PMID15685149

• Boppana SB. Cytomegalovirus. In: Diagnosis of congenital and perinatal infections: A concise guide, Hutto C (ed), The Humana Press Inc. Totowa, NH, 2006, pp 73-86.

• Boppana SB. Epstein-Barr Virus. In: Diagnosis of congenital and perinatal infections: A

concise guide, Hutto C (ed), The Humana Press Inc. Totowa, NH, 2006, pp 87-89. • Boppana SB and Britt WJ. Cytomegalovirus, In: Infection and Hearing Impairment. Newton

VE, Vallely PJ (eds). John Wiley & Sons, Ltd. Chichester, UK, 2006, pp 67-91. • Boppana SB, Fowler KB. Human Cytomegalovirus Persistence in the Population:

Epidemiology and Transmission. Human Herpesviruses: Biology, Therapy and Immunoprophylaxis. Arvin A, Campadielli-flume G, Moore P, Mocarski E, Roizman B, Whitley R (eds). Cambridge University Press, Cambridge, UK., 2007, pp 795-813.

• Boppana SB. Cytomegalovirus. Collaborator, Committee on Infectious Diseases. Red Book,

28th Edition. American Academy of Pediatrics, Elk Grove Village, IL, 2009. • Ross SA, Novak Z, Pati SK, Boppana SB. Overview of the diagnosis of cytomegalovirus

infection. Infect Disord Drug Targets 11(5):466-474, 2011 [Epub June 30, 2011]

Suresh B. Boppana Page 26 • Ross SA, Shimamura M, Boppana SB. CMV Infections. In: Textbook of Clinical Pediatrics.

Elzouki AY, Harfi HA, Naze HM, Stapleton FB, Oh W, Whitley RJ (eds). 2nd Ed. Springer-Verlag Berlin Heidelberg, Heidelberg, Germany, 2011, pp 1145-1162

• Ross SA, Boppana SB. CMV: Diagnosis, Treatment and Considerations on Vaccine

Mediated Prevention. In: Hematology, Immunology and Infectious Disease: Neonatology Questions and Controversies, Ohls R, Maheswari A (eds). 2ed. Elsevier Saunders, Philadelphia, PA 2012, pp 171-188

• Boppana SB, Britt WJ. Synopsis of clinical aspects of human cytomegalovirus disease. In: Cytomegaloviruses: From Molecular Pathogenesis to Intervention. Reddehase MJ (ed). 2nd Ed. Caister Academic Press, Norfolk, U.K., 2013 Volume II, pp II.1. 1-25.

• Boppana SB, Ross SA, Fowler KB. Congenital cytomegalovirus (CMV) infection: clinical

outcome. Clin Infect Dis 57(Suppl 4):S178-!80, 2013

• Boppana SB. Cytomegalovirus Infection. Red Book 2015 Primary Contributor and Leading Content Expert.

• Boppana SB, Britt WJ. Recent Approaches and Strategies in the Generation of Antihuman

Cytomegalovirus Vaccines. Andrew D. Yurochko, William E. Miller (eds.), Human Cytomegaloviruses: Methods and Protocols, Methods in Molecular Biology, 2014; 1119: 311-48. Springer Science + Business Media, New York. doi: 10.1007/978-1-62703-788-4-17. PMID: 24639230.

• Sheffield JS, Boppana SB. Cytomegalovirus infection in pregnancy. UpToDate (online),

February, 2012. Last Major Update: June 30, 2014.

• Pinninti SG, Hough-Telford C, Pati S, Boppana S. Cytomegalovirus and Ebstein-Barr Virus Infections. Pediatrics in Review 37(6):223-234, 2016 • Boppana SB, Britt WJ, Fowler K, Hutto CS, James SH, Kimberlin DW, Poole C, Ross SA,

Whitley RJ. Pathogenesis of Other Congenital Infections. J Infect Dis, 2017:216(S10); S912-8. doi: 10.1093/infdis/jix457. PMID: 28968907

• Boppana SB, Fowler KB. Insight into Long-Term Neurodevelopmental Outcomes in

Congenital Cytomegalovirus Infection. Pediatrics, 140(5): pii: e20172526, 2017. doi: 10.1542/peds.2017-2526. PMID: 2906579. Erratum in: Pediatrics, 2018, Jan 31, 2018.

• Boppana SB. Cytomegalovirus Infection. Red Book 2018 Primary Contributor and Leading Content Expert.

• Boppana SB. Baylisascaris Infections. Red Book 2018 Primary Contributor and Leading Content Expert.

• Plotkin SA, Boppana SB. Vaccination against the human cytomegalovirus. Vaccine, 2018

(Published online April 2, 2018). PMID: 2962379. doi: 10.1016/j.vaccine.2018.02.089.

• Fowler KB, Boppana SB. Congenital cytomegalovirus infection. Semin Perinatol 42(3): 149-154, 2018. doi: 10.1053/j.semperi.2018.02.002. PMID: 29503048

Suresh B. Boppana Page 27 Oral Presentations: • Boppana SB, Pass RF, Britt WJ, Stagno SB, Alford CA. Symptomatic congenital CMV

infection: neonatal morbidity and mortality. Program and Abstracts, 31st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, September 29-October 2, 1991

• Boppana S, Britt W, Polis M, Koenig S. Antibody responses to CMV in HIV-1 seropositive

patients with CMV retinitis. Cold Spring Harbor Laboratory Meeting, "Modern Approaches to New Vaccines Including the Prevention of AIDS", Cold Spring Harbor, New York, September 19-23, 1991

• Boppana S, Britt W. CMV-specific antibody responses in children with primary

asymptomatic congenital CMV. Clin Res 1992, Southern Society for Pediatric Research meeting, Jan. 29-31, 1992, New Orleans, LA

• Boppana SB, Amos CS, Pass RF. Reactivation of chorioretinitis associated with congenital

cytomegalovirus infection. Clin Res, Southern Society for Pediatric Research Annual Meeting, New Orleans, LA, Jan. 21-23, 1993

• Fowler K, McCollister F, Boppana S, Dahle A, Stagno S, Britt W, Pass R. Childhood

deafness: the importance of congenital cytomegalovirus screening. Southern Society for Pediatric Research Annual Meeting, New Orleans, LA, February 3-5, 1994, Clin Res 41:753A, 1993

• Boppana S, Pass R, Amos C. Ophthalmologic abnormalities associated with congenital

cytomegalovirus infection. Southern Society for Pediatric Research Annual Meeting, New Orleans, LA, February 3-5, 1994, Clin Res 41:767A, 1993

• Fowler KB, Dahle AJ, Boppana SB, Stagno S, Britt WJ, Pass RF. Identifying childhood

hearing impairment: the importance of congenital cytomegalovirus infection. Society for Pediatric Epidemiologic Research 7th Annual Meeting, Miami Beach, Florida, June 14-15, 1994

• Boppana SB, Britt WJ. Recognition of individual human cytomegalovirus (HCMV) gene

products by HCMV-specific cytotoxic T cells. 34th Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, FL, October 4-7, 1994

• Pass RF, Duliege, AM, Boppana SB, Britt WJ, Granoff DM, Sekulovich R, Burke RL. A

phase I trial of BIOCINE CMV gB vaccine in seronegative adults. 5th International Cytomegalovirus Conference, Stockholm, Sweden, May 21-24, 1995

• Boppana S. Recognition of individual human cytomegalovirus (HCMV) proteins by HCMV-

specific class I restricted cytotoxic T cells. 20th International Herpesvirus Workshop, Groning, The Netherlands, July 29 - August 3, 1995

• Miller J, Boppana S, Fowler K, Britt W, Pass R, Stagno S. Antiviral antibodies and the

development of sequelae in congenital CMV infection. 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, September 17-20, 1995

Suresh B. Boppana Page 28 • Burke RL, Duliege AM, Sekulovich R, Boppana SB, Britt WJ, Granoff D, Pass R.

Development of CMV vaccines: The subunit approach. 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, September 17-20, 1995

• Duliege AM, Frey S, Boppana S, Yang E, Burke RL, Sekulovich R, Hirabayashi S, Percell

S, Granoff D, Pass R. Recombinant CMV gB subunit vaccine with a novel adjuvant can significantly boost CMV antibody titers in CMV-seropositive adults. 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, September 17-20, 1995

• Boppana S, Fowler K, Britt W, Pass R. Maternal immunity and symptomatic congenital

CMV infection. Program & Abstracts, p 56, Abstract #112. IDSA 34th Annual Meeting, New Orleans, LA, September 18-20, 1996

• Boppana S, Fowler K, Britt W, Stagno S, Pass R. Maternal immunity and symptomatic

congenital CMV infection. First World Congress of Pediatric Infectious Diseases, Acapulco, Mexico, December 4-7, 1996

• Boppana S, Fowler K, Pass R, Mach M, Britt W. Strain specific immune responses and

intrauterine transmission of HCMV in immune mothers. 6th International Cytomegalovirus Workshop, Orange Beach, AL, March 5-9, 1997

• Fowler KB, Dahle A, Boppana SB, Pass RF. Universal auditory screening and congenital

cytomegalovirus infection. Society for Epidemiologic Research Annual Meeting, Edmonton, Alberta, Canada, June 12-14, 1997

• Boppana S, Fowler K, Rivera L, James V, Pass R, Britt W. Virus burden in infancy as a

predictor of outcome in congenital CMV infection. 7th International Cytomegalovirus Workshop, Brighton, United Kingdom, April 28 - May 2, 1999

• Fowler KB, Pass RF, Boppana SB, Britt WJ. Neurodevelopmental deficits in school-aged

children who have asymptomatic congenital cytomegalovirus (CMV) infection. APS/SPR Annual Meeting, San Francisco, CA, May 1-4, 1999

• Boppana SB, Rivera LB, Britt WJ. Maternal reinfection is associated with intrauterine

transmission of human cytomegalovirus in women with pre-existing immunity. 39th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, September 26-29, 1999

• Boppana SB, Rivera LB, Yang J, Mach M, Britt WJ. Congenital CMV infection in offspring of

immune mothers: Role of maternal reinfection. 25th Herpesvirus Workshop, Portland, OR, July 28 – August 3, 2000

• Boppana SB, Britt WJ, Stagno S, Pass RF, Fowler KB. Predictors of outcome in children

with symptomatic congenital CMV infection. APS/SPR Annual Meeting, Baltimore, MD, April 29 - May 2, 2001

• Boppana SB, Rivera LB, Britt WJ, Stagno S, Pass RF, Fowler KB. Predictors of hearing

loss in children with symptomatic congenital CMV infection. 39th Annual Meeting of Infectious Diseases Society of America, San Francisco, CA, October 25-28, 2001

Suresh B. Boppana Page 29 • Bradford RD, Kimberlin DW, Lakeman FD, Cloud G, Boppana SB, Britt WJ, Sanchez P,

Demmler G, Dankner W, Shelton M, Jacobs RF, Whitley RJ, and the NIAID Collaborative Antiviral Study Group (CASG). Baseline viremia in congenital cytomegalovirus (CMV) infection correlates with clinical outcome. 39th Annual Meeting of Infectious Diseases Society of America, San Francisco, CA, October 25-28, 2001

• Boppana SB, Rivera LB, Fowler KB, Yang J, Britt WJ. Viral load in infancy predicts outcome

in children with congenital CMV infection. 41st Interscience Conference on Antimicrobials Agents and Chemotherapy, Chicago, IL, December 16-19, 2001

• Boppana SB, Shimamura M, Britt WJ, Pass RF, Fowler KB. Congenital CMV infection

following a non-primary maternal infection. 3rd World Congress of Pediatric Infectious Diseases – WSPID, Santiago, Chile, November 19-23, 2002

• Boppana S, Fowler K, Britt W, Stagno S, Pass R. Congenital cytomegalovirus infection:

Impact of maternal immunity on outcome. 6th World Congress of Perinatal Medicine, Osaka, Japan, September 13-16, 2003.

• Boppana SB, Novak Z, Vellenki H, Brice S. Frequency of CMV Infections in Healthy

Seropositive Women. 43rd Annual Infectious Diseases Society of America Meeting, San Francisco, CA, October 6-9, 2005.

• Ross SA, Novak Z, Boppana SB. GJB2 and GJB6 mutations in children with congenital

cytomegalovirus infection and hearing loss. Association for Research in Otolaryngology (ARO) Midwinter Meeting, Denver, CO, February 12, 2007.

• Ross SA, Novak Z, Fowler KB, Pass RF, Britt WJ, Boppana SB. Viral load and outcome in

neonates and infants with congenital cytomegalovirus infections. 11th International CMV and Beta Herpesvirus Workshop, Toulouse, France, May 14, 2007.

• Ross SA, Novak Z, Britt W, Fowler K, Pass R, Boppana S. Cytomegalovirus blood load and

hearing in neonates and young children with congenital infection. 45th Annual Infectious Diseases Society of America Meeting, San Diego, CA, October 4-7, 2007.

• Maheshwari A, Hartman Y, Boppana S. Cytomegalovirus sensitizes macrophages to LPS

by upregulating CD14 expression. Pediatric Academic Societies & Asian Society for Pediatric Research Joint Meeting, Honolulu, HI, May 2-6, 2008.

• Arora N, Ross S, Novak Z, Fowler K, Britt W, Boppana S. Viruria and DNAemia in healthy

women with and without Cytomegalovirus reinfections. 48th Annual ICAAD/IDSA 46th Annual Meeting (joint), Washington, DC, Oct 25-28, 2008.

• Boppana S, Ross S, Novak Z, Shimamura M, Britt W, Tolan R, Palmer A, Ahmed A,

Michaels M, Sanchez P, Bernstein D, Fowler K. Evaluation of dried blood spot PCR in screening newborns for congenital CMV infection. Pediatric Academic Societies Annual Meeting, Baltimore, MD, May 2-5, 2009

• Fowler KB, Ross S, Shimamura M, Tolan R, Ahmed A, Palmer A, Michaels M, Bernstein D,

Sanchez P, Britt W, Boppana S. Prevalence of congenital cytomegalovirus (CMV) infection: interim findings of the NIDCD Multicenter CHIMES Study. 12th International CMV/BetaHerpesvirus Workshop, Boston, MA, May 10-14, 2009.

Suresh B. Boppana Page 30 • Boppana S, Ross S, Novak Z, Shimamura M, Britt W, Tolan R, Palmer A, Ahmed A,

Michaels M, Sanchez P, Bernstein D, Fowler K. Evaluation of dried blood spot PCR in screening newborns for congenital CMV infection. 12th International CMV/BetaHerpesvirus Workshop, Boston, MA, May 10-14, 2009.

• Boppana S, Ross S, Novak Z, Chowdhury N, Palmer A, Ahmed A, Michaels M, Sanchez P,

Bernstein D, Tolan R, Fowler K. Saliva PCR for newborn CMV screening. 47th Annual Infectious Diseases Society of America Meeting, Philadelphia, PA Oct 29 - Nov 1, 2009.

• Boppana S, Ross S, Chowdhury N, Novak Z, Ahmed A, Michaels M, Sanchez P, Bernstein

D, Tolan R, Palmer A, Shimamura M, Fowler, K. Dried saliva PCR for screening newborns for congenital CMV infection. Pediatrics Academic Societies Annual Meeting, Vancouver, BC, May 1-4, 2010.

• Ross S, Fowler K, Novak Z, Chowdhury N, Ahmed A, Michaels M, Sanchez P, Bernstein D,

Tolan R, Palmer A, Boppana S. Relationship between dried blood spot positivity and viral load in urine and saliva of infants with congenital cytomegalovirus infection. Pediatric Academic Societies Annual Meeting, Vancouver, BC, May 1-4, 2010

• Fowler KB, McCollister FP, Tolan RW, Ahmed A, Palmer AL, Michaels MG, Bernstein DI,

Sanchez PJ, Boppana SB. Congenital cytomegalovirus infection and newborn hearing screening: interim findings on etiology of hearing loss from the National Institute on Deafness and Other communication Disorders (NIDCD) cytomegalovirus & hearing multicenter (CHIMES) study. NHS 2010 Conference, Cernobbio, Italy, June 8-10, 2010.

• Fowler K, Ross S, Shimamura M, Tolan R, Ahmed A, Palmer A, Michaels M, Bernstein D,

Sanchez P, Boppana S for the CHIMES Study Investigators. Prevalence and clinical characteristics of congenital cytomegalovirus infection in newborns in the NIDCD CHIMES Study. Third International Congenital Cytomegalovirus Conference, Paris, France, September 23-25, 2010.

• Ross S, Fowler K, Novak Z, Chowdhury N, Shimamura M, Michaels M, Sanchez P, Tolan R,

Bernstein D, Ahmed A, Palmer A, Boppana S. Urine and saliva viral load in infants with symptomatic congenital cytomegalovirus infection and hearing loss at birth. Third International Congenital Cytomegalovirus Conference, Paris, France, September 23-25, 2010.

• Boppana S, Ross S, Shimamura M, Ahmed A, Palmer A, Michaels M, Sanchez P, Tolan R,

Bernstein D, Fowler K for the NIDCD CHIMES Study Investigators. Utility of dried blood spot real-time polymerase chain reaction to detect infants with symptomatic congenital cytomegalovirus infection and hearing loss. Third International Congenital Cytomegalovirus Conference, Paris, France, September 23-25, 2010.

• Boppana S, Ross S, Novak Z, Shimamura M, Sanchez P, Tolan R, Bernstein D, Ahmed A, Palmer A, Michaels M, Fowler K for the NIDCD CHIMES Study Investigators. Use of CMV viral load in newborn dried blood spots and saliva to identify infants with CMV-associated hearing loss at birth. 13th International CMV/BetaHerpesvirus Workshop, Nuremberg, Germany, May 14-17, 2011.

• Fowler KB, Tolan RW, Ahmed A, Palmer AL, Michaels MG, Bernstein DI, Sanchez PJ, Boppana SB for the CHIMES Study Investigators. The importance of congenital cytomegalovirus infection in the etiology of childhood hearing loss: interim findings from the National Institute on Deafness and Other Communication Disorders (NIDCD)


Cytomegalovirus & Hearing Multicenter (CHIMES) Study. 13th International CMV/Betaherpesvirus Workshop, Nuremberg, Germany, May 14-17, 2011.

• Pinninti S, Shimamura M, Novak Z, Ross SA, Palmer AL, Ahmed A, Tolan RW, Bernstein DI, Michaels MG, Sanchez PJ, Fowler KB, Boppana SB. Newborn CMV screening: Saliva PCR identifies more infants with congenital CMV infection than rapid culture. Pediatric Academic Societies Annual Meeting, Boston, MA, April 29, 2012.

• Pinninti SG, Pati S, Novak Z, Chowdhury N, Patro R, Ross S, Boppana S. Genotypic diversity and mixed infection is not associated with symptomatic infection and hearing loss in congenital CMV infection. 4th Congenital Cytomegalovirus Conference and 14th International CMV/BetaHerpesvirus Workshop, San Francisco, CA, October 29, 2012 to November 2, 2012.

• Turner KM, Lee HC, Boppana SB, Carlo WA, Randolph DA. The incidence and impact of cytomegalovirus infection in preterm infants. Pediatric Academic Societies Annual Meeting, Washington, DC, May 5, 2013.

• Boppana SB, Ross S, Sanchez P, Bernstein D, Michaels MG, Tolan, R, Ahmed A, Palmer A, and Fowler KB. Evaluation of dried blood spot PCR to detect infants with symptomatic congenital cytomegalovirus infection and hearing loss. Pediatric Academic Societies Annual Meeting, Washington, DC, May 6, 2013.

• Ross SA, Shimamura M, Palmer AL, Ahmed A, Michaels MG, Sánchez PJ, Bernstein DI, Tolan, Jr. RW, Novak Z, Chowdhury N, Britt WJ, Fowler KB, and Boppana SB. Detection of congenital cytomegalovirus infection using real-time polymerase chain reaction or culture of saliva or urine: Which is better? Pediatric Academic Societies Annual Meeting, Washington, DC, May 6, 2013.

• Pinninti SG, Ross S, Palmer A, Ahmed A, Tolan RW, Bernstein DI, Michaels M, Sanchez PJ, Fowler K, Boppana S. Longitudinal salivary cytomegalovirus shedding in a cohort of infants with congenital CMV infection. ID Week 2013, San Francisco, CA, October 3, 2013.

• Dar L, Namdeo D, Kumar P, Kumar A, Rai S, Thakar A, Deorari AK, Kant S, Broor S, Fowler

KB, Boppana SB. Congenital cytomegalovirus infection and hearing loss in a highly seropositive rural population in India. Pediatric Academic Societies Annual Meeting, Vancouver, BC, May 3, 2014.

• Boppana S, Ross S, Pinninti S, Palmer A, Ahmed A, Sanchez P, Michaels M, Bernstein D,

Feja K, Stewart A, Pati S, Fowler K. Association between blood viral load and symptomatic congenital CMV infection and hearing loss at birth: Findings from the NIDCD CHIMES study. Pediatric Academic Societies Annual Meeting, Vancouver, BC, May 4, 2014.

• Oliver SE, Pinninti SG, Pati SK, Palmer AL, Ahmed A, Feja K, Bernstein DI, Michaels MG,

Sanchez PJ, Stewart A, Fowler KB, Boppana SB, Ross SA for the NIDCD CHIMES Study. Saliva viral load in symptomatic congenital CMV infection and CMV-associated hearing loss at birth: Finding from the NIDCD CHIMES study. Pediatric Academic Societies Annual Meeting, Vancouver, BC, May 4, 2014.

• Fowler KB, McCollister FP, Sabo DL, Shoup AG, Owen KE, Woodrfuff JL, Schneider L, Cox

E, Choo D, Boppana SB. A Targeted Approach for Congenial Cytomegalovirus (CMV)


Screening within Newborn Hearing Screening: Findings from the NIDCD CHIMES Study. Pediatric Academic Societies Annual Meeting, Vancouver, BC, May 5, 2014.

• Puhakka L, Lappalainen M, Lonnqvist T, Niemensivu R, Lindahl P, Nieminen T, Chowdhury

N, Boppana S, Saxen H. Congenital cytomegalovirus infection in Finland – a prospective study. 24th European Congress of Clinical Microbiology and Infectious Diseases, Barcelona, Spain, May 12, 2014.

• Ross S, Pinninti S, Ahmed A, Palmer A, Michaels M, Sanchez P, Bernstein D, Tolan R,

Novak Z, Chowdhury N, Fowler K, Boppana S. Saliva is the preferred sample for congenital CMV diagnosis. Cytomegalovirus Public Health and Policy Conference, Salt Lake City, UT, September 26-27, 2014.

• Ross SA, Sanchez PJ, Palmer AL, Ahmed A, Feja K, Bernstein DI, Michaels MG, Stewart A,

Boppana SB, Fowler KB for the National Institute on Deafness and Other Communication Disorders CMV and Hearing Multicenter Screening (CHIMES) Study. Laboratory and neuroimaging evaluation of asymptomatic infants with congenital cytomegalovirus infection: Findings from the NIDCD CHIMES Study. The 5th Congenital CMV Conference and 15th International CMV/BetaHerpesvirus Workshop, Brisbane, Australia, April 20-24, 2015.

• Dar L, Namdeo D, Kabra M, Rai S, Thakar A, Deorari AK, Kant S, Fowler KB, Boppana SB.

Congenital Cytomegalovirus Infection, Permanent Congenital or Early-Onset Hearing Loss and Connexin Gene Mutations in Rural North India. The 5th Congenital CMV Conference and 15th International CMV/BetaHerpesvirus Workshop, Brisbane, Australia, April 20-24, 2015.

• Pinninti S, Rodgers M, Novak Z, Britt W, Fowler K, Boppana S, Ross S. Predictors of

sensorineural hearing loss (SNHL) and neurodevelopmental outcome in infants with symptomatic congenital cytomegalovirus (cCMV) infection. The 5th Congenital CMV Conference and 15th International CMV/BetaHerpesvirus Workshop, Brisbane, Australia, April 20-24, 2015.

• Boppana SB, Ross SA, Palmer AL, Ahmed A, Bernstein DI, Michaels MG, Sanchez PJ,

Stewart A, Feja K, Fowler KB for the CHIMES Study Investigators. Cytomegalovirus (CMV)-associated Hearing Loss – Findings from the NIDCD CHIMES Study. 2016 Association for Research in Otolarynogology MidWinter Meeting, San Diego, CA, February 21-24, 2016.

• Ross SA, Michaels MG, Ahmed A, Palmer AL, Sanchez PJ , Bernstein DI, Feja K , Stewart

A , Boppana SB, Fowler KB. False Positive Rates of Saliva PCR Assay for Newborn Cytomegalovirus Screening. Pediatric Academic Societies Meeting, Baltimore, MD, April 30-May 3, 2016.

• Ross SA, Sanchez PJ , Bernstein DI, Michaels MG, Ahmed A, Palmer AL, Stewart A, Feja K, Fowler KB, Boppana SB. Dried Blood Spot PCR as a Marker for Hearing Loss in Congenital CMV Infection. Pediatric Academic Societies Meeting, Baltimore, MD, April 30-May 3, 2016.

• Gantt S, Dionne F, Kozak FK, Goshen O, Goldfarb DM, Park A, Boppana S, Fowler K.

Cost-effectiveness of universal and targeted newborn screening for congenital cytomegalovirus infection. CMV Public Health and Policy Conference, Austin, TX, September 26-27, 2016.

Suresh B. Boppana Page 33 • Ross S, Boppana S, Fowler K. Is it time for universal newborn congenital cytomegalovirus

(CMV) screening in the United States? CMV Public Health and Policy Conference, Austin, TX, September 26-27, 2016.

• Ross S, Fowler K, Boppana S. Management of infants identified on cytomegalovirus (CMV)

screening with asymptomatic congenital CMV infection – what to do with all the babies? CMV Public Health and Policy Conference, Austin, TX, September 26-27, 2016.

• Boucoiran I, Boppana S, Gantt S, Mayer BT, Schiffer J, Wald A, Krantz EM, Corey L,

Casper C. Recurrent maternal CMV infection following primary infection in infants. CMV Public Health and Policy Conference, Austin, TX, September 26-27, 2016.

• Boppana S, Ross S, Britt W, Fowler K. Breastfeeding does not impact saliva PCR results

for newborn CMV screening. CMV Public Health and Policy Conference, Austin, TX, September 26-27, 2016.

• Fowler K, Davies S, Kempf M, Boppana S, Cannon M, Tita A, Edwards R. Increasing awareness and promoting strategies for prevention of congenital cytomegalovirus infection (cCMV) among young pregnant women. CMV Public Health and Policy Conference, Austin, TX, September 26-27, 2016.

• Fowler K, Ross S, Boppana S. Management of infants identified on cytomegalovirus (CMV)

screening with asymptomatic congenital CMV infection – what to do with all the babies? CMV Public Health and Policy Conference, Austin, TX, September 26-27, 2016.

• Fowler KB, Davies SL, Kempf MC, Boppana SB, Cannon MJ, Tita A, Edwards RK.

Increasing Awareness and Promoting Strategies for Prevention of Congenital Cytomegalovirus Infection (cCMV) Among Young Pregnant Women. CMV2017 6th International Congenital CMV Conference & 16th International CMV/betaherpesvirus Workshop. Noordwijkerhout, the Netherlands. April 30 – May 4, 2017.

• Ross SA, Ahmed A, Palmer AL, Michaels MG, Sánchez PJ, Stewart A, Bernstein DI, Feja K,

Fowler KB, Boppana SB. Characteristics and outcome of symptomatic congenital CMV infection: Findings from the CHIMES Study. CMV2017 6th International Congenital CMV Conference & 16th International CMV/betaherpesvirus Workshop. Noordwijkerhout, the Netherlands. April 30 – May 4, 2017.

• Sabbaj S, Moylan D, Pati S, Ross S, Boppana S. Breast milk HCMV viral load drives the

establishment of breast milk CMV-pp65-specific CD8 T cells in HCMV infected mothers. CMV2017 6th International Congenital CMV Conference & 16th International CMV/betaherpesvirus Workshop. Noordwijkerhout, the Netherlands. April 30 – May 4, 2017.

• Christy J, Fowler KB, Pinninti S, Boppana SB. Vestibular and Balance Disorders in Children

with Congenital Cytomegalovirus Infection. Pediatric Academic Societies Annual Meeting, Toronto, ON. May 4 – May 8, 2018

• Park A, Boppana S, Rawlinson W, Goldfarb DM, van Zuylen W, Thiesset HT, Pati S, Latting

MP, Gantt S. Evaluation of the illumigene assay for newborn cytomegalovirus screening using oral swab samples. CMV Public Health and Policy Conference, Burlington, VT, September 23-25, 2018.

• Yamamoto AY, Anastacio ART, Tanaka EM, Manfredi AK, Fowler KB, Boppana S, Britt W,

Mussi-Pinhata M. Can congenital CMV-related hearing loss be evaluated without systematic


neonatal CMV screening? CMV Public Health and Policy Conference, Burlington, VT, September 23-25, 2018.

• Christy J, Almutairi A, Fowler KB, Pinninti S, Boppana S. Vestibular and balance disorders

in children with asymptomatic congenital cytomegalovirus infection. CMV Public Health and Policy Conference, Burlington, VT, September 23-25, 2018.

• Yamamoto AY, Mussi-Pinhata M, Britt W, Aragon DC, Lanzieri T, Fowler KB, Boppana S,

Risk of intrauterine growth restriction among infants with and without congenital cytomegalovirus (CMV) infection. CMV Public Health and Policy Conference, Burlington, VT, September 23-25, 2018.

Poster Presentations: • Boppana SB, Mandelbaum DE. Acute cerebellar ataxia; a possible etiologic role for Group

A beta hemolytic streptococcal infection. American Academy of Neurology Annual Meeting, Cincinnati, OH, 1988, Neurology 38:317, 1988

• Boppana SB, Frick OL, German DF. Localized form of seminal plasma allergy (SPA).

American College of Allergy and Immunology Annual Meeting, 1990, Allergy 64:98, 1990

• Boppana SB, Fowler KB, Pass RF, Britt WJ, Stagno S, Alford CA. Newborn findings and outcome in children with symptomatic congenital CMV infection. ASP/SPR Annual Meeting, Baltimore, MD, May 4-7, 1992. Pediatric Research 31:158A, 1992

• Boppana SB, Britt WJ. Cytomegalovirus specific antibody responses in mothers of children

with asymptomatic congenital CMV infection. APS/SPR Annual Meeting, Baltimore, Maryland, May 4-7, 1992. Pediatric Research 31:158A, 1992

• Boppana SB, Britt WJ. Virus specific antibody responses in primary maternal

cytomegalovirus infection. 17th International Herpesvirus Workshop, Edinburgh, Scotland, August 1-6, 1992

• Boppana S, Alford C, Whitley R, Britt W. Altered antibody responses in congenital

cytomegalovirus infection treated with ganciclovir. Program and Abstracts, 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy, Abstract #1422, p 348, Anaheim, California, October 11-14, 1992

• Boppana S, Britt W. Antiviral antibody responses in primary maternal cytomegalovirus

infection. Fourth International Cytomegalovirus Conference, Paris, France, April 18-21, 1993

• Boppana S, Britt W. Virus specific antibody responses and intrauterine transmission in primary cytomegalovirus infection. Program and Abstracts, 33rd Conference on Antimicrobial Agents and Chemotherapy, New Orleans, LA, Oct. 17-20, 1993

• Pass RF, Fowler KB, Stagno S, Britt WJ, Boppana SB, Alford CA. Gestational age at time

of maternal infection and outcome of congenital cytomegalovirus infection. ASP/SPR Annual Meeting, Seattle, WA, May 2-5, 1994, Pediatr Res 35:191A, Abstract #1130, 1994

• Fowler KB, Dahle A, Boppana SB, Stagno S, Britt WJ, Pass RF. The importance of

congenital cytomegalovirus infection in identifying childhood hearing impairment. APS/SPR Annual Meeting, Seattle, WA, May 2-5, 1994, Pediatric Research 35:296A, Abstract #1763,


1994

• Boppana SB, Britt WJ. Maternal antiviral antibody response and intrauterine transmission in cytomegalovirus infection. APS/SPR Annual Meeting, Seattle, WA, May 2-5, 1994, Pediatric Research 35:294A, Abstract #1749, 1994

• Pass RF, Duliege, AM, Boppana SB, Britt WJ, Granoff DM, Sekulovich R, Burke RL.

Immunogenicity of a recombinant CMV gB vaccine. ASP/SPR Annual Meeting, Seattle, CA, May 7-11, 1995

• Boppana SB, Fowler KB, Stagno S, Britt WJ, Pass RF. CT scan findings and outcome in

children with symptomatic congenital CMV infection. 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, September 17-20, 1995

• Boppana SB, Britt WJ. Recognition of individual human cytomegalovirus (HCVM) proteins

by HCMV-specific class I MHC restricted cytotoxic T cells. American Academy of Allergy Asthma and Immunology 1996 International Conference, New Orleans, LA, March 15-20, 1996. J Allergy Clin Immunol (Abstract #926) 97:414, 1996

• Boppana SB, Britt WJ. Recognition of individual human cytomegalovirus (HCVM) proteins

by HCMV-specific class I MHC restricted cytotoxic T cells. American Academy of Allergy Asthma and Immunology 1996 International Conference, New Orleans, LA, March 15-20, 1996. J Allergy Clin Immunol (Abstract #926) 97:414, 1996

• Pass RF, Duliege AM, Sekulovich R, Boppana S, Percell S, Hirabayashi S, Britt WJ, Burke

RL. Antibody response to a fourth dose of CMV gB in healthy adults. 6th International Cytomegalovirus Workshop, Orange Beach, AL, March 5-9, 1997

• Boppana S, Fowler K, Pass R, Mach M, Britt W. Strain-specific immune responses and

intrauterine transmission of HCMV in seropositive women. 22nd International Herpesvirus Workshop, La Jolla, CA, August 2-8, 1997

• Boppana S, Yoo C, Weston P, Britt W, Posnett D. T cell receptor repertoire in congenital

cytomegalovirus infection. APS/SPR Annual Meeting, New Orleans, LA, May 1-5, 1998

• Boppana SB, Rivera L. Cytokine profiles in infants with congenital cytomegalovirus infection. APS/SPR Annual Meeting, New Orleans, LA, May 1-5, 1998

• Boppana SB, Pass RF, Britt WJ. Cell-mediated immune responses and cytokine profiles in

congenital CMV infection. 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA, September 24-27, 1998

• Boppana SB, Fowler KB, Rivera L, James VG, Pass RF, Britt WJ. Virus burden

measurement in early infancy and outcome in congenital CMV infection. APS/SPR Annual Meeting, San Francisco, CA, May 1-4, 1999

• Boppana S, Fowler K, Rivera L, James V, Pass R, Britt W. Virus burden in early infancy as

predictor of long-term outcome in congenital CMV infection. XIth International Congress of Virology, Sydney, Australia, August 9-13, 1999

• Boppana SB, Rivera LB, Yang J. Characterization of antigen specific T cell responses in

children with congenital CMV infection. 40th Interscience Conference on Antimicrobials


Agents and Chemotherapy, Toronto, Ontario, Canada, September 17-20, 2000

• Novak Z, Rivera L, Boppana S. Antigen specific T-cell responses in children with congenital CMV infection. 40th Annual Meeting of Infectious Diseases Society of America, Chicago, IL, October 23-26, 2002

• Novak Z, Rivera L, Boppana, S. CMV reinfections are common in healthy seropositive

individuals. 41st Annual Meeting of Infectious Diseases Society of America, San Diego, CA, October 9-12, 2003.

• Ross S, Fowler K, Ashrith G, Pass R, Britt, W, Stagno S, Boppana S. Hearing loss in

children with congenital CMV infection born to mothers with preexisting immunity. 2004 Pediatric Academic Societies Meeting, San Francisco, CA, May 1-4, 2004.

• Ashrith G, Novak Z, Brice S, Fowler K, Boppana, S. Dried blood spot PCR to screen

newborns for congenital cytomegalovirus infection. 2004 Pediatric Academic Societies Annual Meeting, San Francisco, CA, May 1-4, 2004.

• Ross S, Novak Z, Ashrith G, Rivera L, Hedges S, Schwebke J, Boppana S. Association

between genital tract CMV infection and bacterial vaginosis. 42nd Annual Meeting of Infectious Diseases Society of America, Boston, MA, September 30 – October 2, 2004

• Ross S, Novak Z, Ashrith G, Hedges S, Schwebke J, Boppana, S. Genital Tract

Cytomegalovirus Infection: Virus Strain Diversity and Inflammation. 10th International Cytomegalovirus Workshop, Williamsburg, VA, April 24-28, 2005.

• Novak Z, Ross S, Kumbhla A, Boppana S. Connexin 26 Mutations in CMV Related Hearing

Loss. 10th International Cytomegalovirus Workshop, Williamsburg, VA, April 24-28, 2005. • Stancik LN, Cannon MJ, Fowler KB, Schmid S, Boppana SB, Britt WJ, Pass RF, Stagno S.

Does Duration of Cytomegalovirus (CMV) Shedding Predict Delayed Hearing Loss? Results From a Longitudinal Study of Children Born with Congenital CMV. 10th International Cytomegalovirus Workshop, Williamsburg, VA, April 24-28, 2005.

• Novak Z, Ross SA, Vellanki H, Kumbla R, Boppana SB. Cytomegalovirus Strain Diversity in

Healthy Seropositive Women. 43rd Annual Infectious Diseases Society Meeting, San Francisco, October 6-9, 2005.

• Stancik L, Cannon M, Fowler K, Boppana S, Britt W, Pass R, Schmid S, Stagno S. Does

duration of cytomegalovirus (CMV) shedding predict delayed hearing loss? Results from a longitudinal study of children born with congenital CMV. 43rd Annual Infectious Diseases Society of America Meeting, San Francisco, October 6-9, 2005.

• Novak Z, Ross SA, Patro RK, Pati S, Vellanki H, Guha A, Rivera LB, Fowler K, Britt W,

Boppana SB. Frequency of CMV reinfections in seropositive women. 11th International CMV and Beta Herpesvirus Workshop, Toulouse, France, May 13-17, 2007.

• Dar L, Patro RK, Pati SK, Rai S, Kant S, Deorari AK, Broor S, Fowler K, Boppana SB.

Congenital CMV infections in a highly seropositive population in Delhi, India. 11th International CMV and Beta Herpesvirus Workshop, Toulouse, France, May 13-17, 2007.

• Pati SK, Dar L, Patro RK, Deorari AK, Rai S, Kant S, Broor S, Boppana SB. Human


cytomegalovirus gB genotypes among CMV strains from children with congenital CMV infection in India. 11th International CMV and Beta Herpesvirus Workshop, Toulouse, France, May 13-17, 2007.

• Yamamoto AY, Mussi-Pinhata MM, Boppana SB, Novak Z, Wagatsuma VM, Frizzo P,

Duarte G, Britt W. Maternal CMV reinfection is a correlate of intrauterine transmission in a highly immune population. Pediatric Academic Societies & Asian Society for Pediatric Research Joint Meeting, Honolulu, HI, May 2-6, 2008.

• Ross SA, Novak Z, Fowler KB, Arora N, Britt WJ, Boppana SB. Blood viral load in infancy

and early childhood is a poor positive predictor of hearing loss in congenital CMV infection. 33rd International Herpesvirus Workshop, Estoril, Portugal, July 27-August 1, 2008.

• Arora N, Novak Z, Ross SA, Reddy M, Fowler KB, Britt WJ, Boppana SB. Occurrence of

CMV reinfections with new virus strains is frequent in seroimmune women. 33rd International Herpesvirus Workshop, Estoril, Portugal, July 27-August 1, 2008.

• Ross SA, Novak Z, Reddy M, Britt WJ, Boppana SB. A novel ELISA method to detect

strain-specific CMV antibodies. 48th Annual ICAAD/IDSA 46th Annual Meeting (joint), Washington, DC, Oct 25-28, 2008.


Michaels M, Sanchez P, Bernstein D, Fowler K. Evaluation of dried blood spot PCR in screening newborns for congenital CMV infection. Pediatric Academic Societies Annual Meeting. Baltimore, MD, May 2-5, 2009.

• Ross S, Danthuluri VR, Novak Z, Blumenthal J, Arora N, Fowler K, Britt W, Boppana S.

Cytomegalovirus strain diversity and infection with multiple strains in congenitally infected infants. 12th International CMV/BetaHerpesvirus Workshop, Boston, MA, May 10-14, 2009.

• Novak Z, Ross SA, Rivera L, Boppana S. Functional T-cell responses in children with

congenital cytomegalovirus infection. 12th International CMV/BetaHerpesvirus Workshop, Boston, MA, May 10-14, 2009.


Michaels M, Sanchez P, Bernstein D, Fowler K. Evaluation of dried blood spot PCR in screening newborns for congenital CMV infection. 12th International CMV/BetaHerpesvirus Workshop, Boston, MA, May 10-14, 2009.

• Fowler KB, Ross S, Shimamura M, Tolan R, Ahmed A, Palmer A, Michaels M, Bernstein D,

Sanchez P, Britt W, Boppana S. Prevalence of congenital cytomegalovirus (CMV) infection: interim findings of the NIDCD Multicenter CHIMES Study. 12th International CMV/BetaHerpesvirus Workshop, Boston, MA, May 10-14, 2009.

• Ross S, Fowler K, Novak Z, Chowdhury N, Ahmed A, Michaels M, Sanchez P, Bernstein D,

Tolan R, Palmer A, Boppana S. Utility of direct real-time PCR on newborn urine to detect and quantify cytomegalovirus. Infectious Diseases Society of America Annual Meeting, Philadelphia, PA, October 29 – November 1, 2009.

Suresh B. Boppana Page 38 • Yamamoto AY, Mussi-Pinhata MM, Carvalho e Oliveira PF, Isaac MDL, Aragon DC, da Silva

Manfredi AK, Britt WJ, Boppana SB. Prevalence and predictors of sensorineural hearing loss in Brazilian children with congenital CMV infection. Pediatric Academic Societies Annual Meeting, Vancouver, BC, May 1-4, 2010.

• Cannon M, Wang C, Pati S, Boppana S, Novak Z, Mayer K, Rompalo A, Sobel J, Klein R,

Bialek S, Gardner L, Dollard S. Incidence of cytomegalovirus reinfection in CMV-seropositive women with or at risk for HIV infection. Third International Congenital Cytomegalovirus Conference, Paris, France, September 23-25, 2010.

• Ross S, Pati S, Arora N, Patro RK, Fowler K, Novak Z, Ahmed A, Michaels M, Sanchez P,

Bernstein D, Tolan R, Palmer A, Boppana S. Cytomegalovirus strain diversity in newborns with congenital infection. Infectious Diseases Society of America 48th Annual Meeting, Vancouver, October 21-24, 2010.

• Ross S, Pati S, Arora N, Novak Z, Sanchez PJ, Tolan RW Jr., Bernstein D, Ahmed A, Palmer A, Michaels M, Shimamura M, Fowler K, Boppana S. Salivary shedding of cytomegalovirus in children with congenital infection. Infectious Diseases Society of America 49th Annual Meeting, Boston, MA, October 20-23, 2011.

• Pinninti SG, Pati S, Novak Z, Chowdhury N, Patro R, Ross S, Boppana S. Genotypic diversity and mixed infection is not associated with symptomatic infection and hearing loss in congenital CMV infection. 4th Congenital Cytomegalovirus Conference and 14th International CMV/BetaHerpesvirus Workshop, San Francisco, CA, October 29, 2012 to November 2, 2012.

• Novak Z, Hendricson RC, Boppana SB, Ross SA. Enrichment of viral DNA in clinical

samples for next generation sequencing of human cytomegalovirus. 4th Congenital Cytomegalovirus Conference and 14th International CMV/BetaHerpesvirus Workshop, San Francisco, CA, October 29, 2012 to November 2, 2012.

• Patro RK, Novak Z, Pritchard MN, Boppana SB, Ross SA. Transcriptome profiling of clinical human cytomegalovirus during replication in different cells. 4th Congenital Cytomegalovirus Conference and 14th International CMV/BetaHerpesvirus Workshop, San Francisco, CA, October 29, 2012 to November 2, 2012.

• Dreher MA, Arora N, Fowler KB, Novak Z, Britt WJ, Boppana SB, Ross SA. Referral bias in

estimating disease and outcome in children with Symptomatic Congenital Cytomegalovirus Infection. 4th Congenital Cytomegalovirus Conference and 14th International CMV/BetaHerpesvirus Workshop, San Francisco, CA, October 29, 2012 to November 2, 2012.

• Fowler KB, Mixon E, Brumbach A, Kempf MC, Ross S, Boppana S for the CHIMES Study

Investigators. Acceptability of Newborn Cytomegalovirus (CMV) Screening in Minority Women: Findings from the NIDCD CHIMES Study. Pediatric Academic Societies Annual Meeting, May 3, 2014.

• Pinninti S, Ross S, Rodgers M, Shimamura M, Palmer A, Ahmed A, Sanchez P, Michaels M,

Bernstein D, Feja K, Stewart A, Fowler K, Boppana S. Characteristics of symptomatic congenital CMV infection: Findings from the NIDCD CHIMES Study. Pediatrics Academic Societies Annual Meeting, May 3, 2014.

Suresh B. Boppana Page 39 • Fowler K, Ross S, Shimamura M, Ahmed A, Palmer A, Michaels M, Bernstein D, Sanchez P,

Feja K, Stewart A, Boppana S, for the CHIMES Study Investigators. Racial Disparities and the prevalence of congenital cytomegalovirus infection: Findings from the NIDCD CHIMES Study. Pediatric Academic Societies Annual Meeting, May 3, 2014.

• Fowler KB, Ross SA, Shimamura M, Ahmed A, Palmer AL, Michaels MG, Bernstein DI,

Sanchez PJ, Feja K, Stewart A, Boppana SB. Adolescent pregnancies and the risk for congenital cytomegalovirus (CMV) infection: Findings from the NIDCD CHIMES Study. Pediatric Academic Societies Annual Meeting, May 5, 2014.

• Ross S, Oliver S, Pinninti S, Pati S, Palmer A, Ahmed A, Feja K, Bernstein D, Michaels M,

Sanchez P, Stewart A, Fowler K, Boppana S. Saliva and dried blood spot viral load in symptomatic congenital cytomegalovirus (CMV) infection and CMV-associated hearing loss at birth. 32nd Annual Meeting, European Society for Paediatric Infectious Diseases, Dublin, Ireland, May 6-10, 2014.

• Fowler K, Mixon E, Brumbach A, Kempf M, Ross S, Boppana S. Acceptability of Newborn

Cytomegalovirus (CMV) Screening in Women: Findings from the NIDCD CHIMES Study. Cytomegalovirus Public Health and Policy Conference, Salt Lake City, UT, September 26-27, 2014.

• Oliver S, Brennan S, Pati S, Kimberlin DW, Boppana S, Ross S. Viral diversity and

neutralizing antibody responses in infants with symptomatic congenital CMV disease receiving antiviral therapy. IDWeek 2014, Philadelphia, PA, October 8-12, 2014.

• Pinninti SG, Ross S, Novak Z, Palmer A, Ahmed A, Sanchez PJ, Michaels M, Bernstein D, Feja KN, Stewart A, Fowler K, Boppana S, and CMV and Hearing Multicenter Screening (CHIMES) Study. Saliva vs urine PCR: The ideal sample for congenital CMV screening and diagnosis. IDWeek 2014, Philadelphia, PA, October 8-12, 2014.

• Pinninti SG, Dreher M, Fowler K, Novak Z, Britt WJ, Boppana S, Ross S. Predictors of sensorineural hearing loss (SNHL) in infants with symptomatic congenital CMV infection. IDWeek 2014, Philadelphia, PA, October 8-12, 2014.

• Ross SA, Pinninti SG, Palmer AL, Ahmed A, Feja K, Bernstein DI, Michaels MG, Sanchez

PJ, Stewart A, Novak Z, Fowler KB and Boppana SB for the CHIMES Study Investigators. Optimal specimen type and method for newborn CMV screening: Findings from the NIDCD CHIMES Study. The 5th Congenital CMV Conference and 15th International CMV/BetaHerpesvirus Workshop, Brisbane, Australia, April 20-24, 2015.

• Hough-Telford C, Pinninti SG, Fowler KB, Boppana SB, Ross SA for the CHIMES Study

Investigators. Predictors of sensorineural hearing loss (SNHL) in newborns with symptomatic congenital cytomegalovirus infection: Data from the NIDCD CHIMES Study. The 5th Congenital CMV Conference and 15th International CMV/BetaHerpesvirus Workshop, Brisbane, Australia, April 20-24, 2015.

• Pati SK, Puhakka L, Pinninti SG, Ross SA, Novak Z, Fowler KB, Olusanya BO, Saxen H and

Boppana SB. Genetic diversity of cytomegalovirus (CMV) strains in congenitally infected infants from different geographic regions. The 5th Congenital CMV Conference and 15th International CMV/BetaHerpesvirus Workshop, Brisbane, Australia, April 20-24, 2015.

Suresh B. Boppana Page 40 • Fowler KB, Davies SL, Kempf MC, Boppana SB, Cannon MJ, Edwards RK. Lack of

Awareness and Knowledge about Congenital Cytomegalovirus (CMV) Infection in Young Urban Pregnant Women. The 5th Congenital CMV Conference and 15th International CMV/BetaHerpesvirus Workshop, Brisbane, Australia, April 20-24, 2015.

• Ross S, Alliu SE, Boppana S, Fowler KB. Universal newborn screening for congenital

Cytomegalovirus infection. The 5th Congenital CMV Conference and 15th International CMV/BetaHerpesvirus Workshop, Brisbane, Australia, April 20-24, 2015.

• Puhakka L, Lappalainen M, Lönnqvist T, Nupponen I, Niemensivu R, Nieminen T, Seuri R,

Lindahl P, Pati S, Chowdhury N, Purser M, Boppana S, Saxen H. Congenital Cytomegalovirus Infection in Finland – A Prospective Cohort Study of 20,000 Infants. The 5th Congenital CMV Conference and 15th International CMV/BetaHerpesvirus Workshop, Brisbane, Australia, April 20-24, 2015.

• Yamamoto AY, Anastasio ART, Reis ACMB, de Lima Isaac M, Tanaka EM, da Silva

Manfredi AK, Barbosa NG, Carnevale A, Boppana SB, Fowler K, Britt WJ, Mussi-Pinhata MM. Contribution of congenital CMV infection to hearing loss at birth in a highly CMV seropositive maternal population. The 5th Congenital CMV Conference and 15th International CMV/BetaHerpesvirus Workshop, Brisbane, Australia, April 20-24, 2015.

• Fowler KB, Davies SL, Kempf MC, Boppana SB, Tita AT, Edwards RK. Increasing

awareness & promoting strategies for prevention of congenital cytomegalovirus infection (cCMV) among young urban pregnant women. Pediatric Academic Societies Meeting, Baltimore, MD, April 30-May 3, 2016.

• Giersch ABS, Shen J, Boppana S, Cohen MS, Hochschild J, Kenna M, Sunyaev S,

Talkowski M, Toro MR, Morton CC. Sequencing a baby for an optimal outcome: A clinical genomic application of newborn hearing screening. Molecular Biology of Hearing and Deafness, Wellcome Genome Campus, Hinxton, Cambridge, UK, May 17-20, 2016.

• Boppana SB, Ross S, Pati S, Britt WJ, Fowler K. Breastfeeding and newborn CMV

screening using saliva. ID Week 2016, New Orleans, LA, October 27, 2016 • Pati S, Novak Z, Boppana SB, Fowler K, Ross S. Cytomegalovirus shedding in saliva and

hearing loss in congenital CMV infection. ID Week 2016, New Orleans, LA, October 27, 2016

• Fowler KB, Ross SA, Tita A, Boppana SB, Britt WJ. Cytomegalovirus Seropositivity and

Adverse Pregnancy Outcomes in an Urban Cohort. CMV2017 6th International Congenital CMV Conference & 16th International CMV/betaherpesvirus Workshop. Noordwijkerhout, the Netherlands. April 30 – May 4, 2017.

• Fowler KB, Ross SA, Ahmed A, Palmer AL, Michaels MG, Bernstein DI, Sánchez PJ, Feja

K, Stewart A, Boppana SB. Degree and Audiometric Patterns of Cytomegalovirus-Related Sensorineural Hearing Loss in Children: Findings from the CHIMES Study. CMV2017 6th International Congenital CMV Conference & 16th International CMV/betaherpesvirus Workshop. Noordwijkerhout, the Netherlands. April 30 – May 4, 2017.

• Dobbins GC, Pati A, Hendrickson C, Britt WJ, Fowler KB, Boppana SB. Ross SA. Next

Generation Sequencing of Congenital Cytomegalovirus Genome Identifies Variants Associated with Symptomatic Infection and Hearing Loss. CMV2017 6th International


Congenital CMV Conference & 16th International CMV/betaherpesvirus Workshop. Noordwijkerhout, the Netherlands. April 30 – May 4, 2017.

• Puhakka L, Lappalainen M, Niemensivu R, Lindahl P, Lönnqvist T, Seuri R, Nupponen I,

Nieminen T, Pati S, Boppana S, Saxen H. Congenital CMV infection in Finland - a prospective cohort study. CMV2017 6th International Congenital CMV Conference & 16th International CMV/betaherpesvirus Workshop. Noordwijkerhout, the Netherlands. April 30 – May 4, 2017.

• Mussi-Pinhata MM, Nayara G Barbosa NG, Yamamoto AY, Duarte G, Fowler K, Boppana

S, Britt WJ. Cytomegalovirus (CMV) shedding in seropositive pregnant women from a high seroprevalence population (BRACHS Study). CMV2017 6th International Congenital CMV Conference & 16th International CMV/betaherpesvirus Workshop. Noordwijkerhout, the Netherlands. April 30 – May 4, 2017.

• Jariwala RH, Ross SA, Boppana SB, Pinninti S. Role of PCR of mucocutaneous samples

and the significance of blood PCR in neonatal HSV infection. Pediatric Academic Societies Annual Meeting, San Francisco, CA. May 4 – 8, 2017.

• Curl A, Yarbrough A, Boppana S, Ross A. Outcomes of outpatient parenteral antimicrobial

therapy in a pediatrics hospital. 8th Annual International Pediatric Antimicrobial Stewardship Conference, St. Louis, MO. June 1-2, 2017.

Other Invited Presentations: • UAB School of Medicine, Department of Pediatrics Noon Conference. Presentation:

Antibiotic Therapy. March 30, 1994 • Southeastern Regional Herpesvirus Conference, Atlanta, Georgia. Presentation: Cytotoxic T

Lymphocyte Activity Following Human Cytomegalovirus Infection. May 2, 1995 • UAB School of Medicine, Pediatrics Emergency Medicine Fellows Conference.

Presentation: Tick-Borne Diseases. August 15, 1995

• Baptist Medical Center, Montgomery, Alabama, Pediatric Section meeting. Presentation: RSV Infections: Diagnosis and Management. November 20, 1995

• UAB School of Medicine, Department of Pediatrics Noon Conference. Presentation:

Antibiotic Therapy. July 23, 1996 • UAB School of Medicine, Second Year Medical Student Lecture. Presentation: Physical

Diagnosis. October 24, 1996 • UAB School of Medicine, Pediatric Emergency Medicine Fellows Conference. Presentation:

Bacterial Resistance Update. February 25, 1997

• UAB School of Medicine, Department of Pediatrics Grand Rounds. Presentation: Infective Endocarditis. February 20, 1997


Antibiotic Therapy. July 24, 1997

Suresh B. Boppana Page 42 • UAB School of Medicine, Department of Pediatrics Noon Conference. Presentation:


• UAB School of Medicine, Department of Pediatrics Nutrition Conference. Presentation: Central Venous Line Infections. November 6, 1998

• UAB School of Medicine, Department of Pediatrics Faculty Lecture Series. Presentation:


• UAB School of Medicine, Department of Medicine, Infectious Diseases Fellowship Orientation Lecture Series. Presentation: CMV Infections. July 23, 1999

• UAB School of Medicine, Pediatric Emergency Medicine Fellows Conference. Presentation:

Tick Borne Infections. August 31, 1999 • UAB School of Medicine, Department of Pediatrics Child Health Investigative Forum.

Presentation: Maternal immunity and congenital CMV infection: Challenging the dogma. May 19, 2000

• UAB School of Medicine, Department of Medicine, Infectious Diseases Fellowship

Orientation Lecture Series. Presentation: CMV Infections. July 21, 2000 • UAB School of Medicine, Department of Pediatrics Grand Rounds. Presentation:

Congenital CMV Infection – Update. February 8, 2001

• UAB School of Medicine, Department of Pediatrics Noon Conference. Presentation: Congenital Syphilis. February 14, 2001

• UAB School of Medicine, Perinatal Grand Rounds. Presentation: Congenital CMV Infection.

November 12, 2002.

• UAB School of Medicine, Department of Medicine, Infectious Diseases Grand Rounds. Presentation: CMV reinfections: Myth or Reality. December 19, 2002.

• UAB School of Medicine, Department of Pediatrics, Allergy and Immunology Division

Conference. Presentation: Congenital CMV Infection – Update. July 16, 2004.

• UAB School of Medicine, Department of Pediatrics Noon Conference. Presentation: Congenital Syphilis. November 14, 2005


Neonatal Infections. August 31, 2009. • UAB School of Medicine, Department of Pediatrics Noon Conference. Presentation:

Immunology of Infectious Diseases. February 3, 2010 • UAB School of Medicine, Department of Pediatrics Noon Conference. Presentation:

Infectious Disease Immunology. June 26, 2013

• UAB School of Medicine, Department of Pediatrics, Pediatric Infectious Diseases Fellow Teaching Conference. Presentation: Immunodeficiencies, February 9, 2015

Suresh B. Boppana Page 43 • UAB School of Medicine, Department of Pediatrics Noon Conference. Presentation:

Congenital Infections. October 11, 2017

Documents

CURRICULUM VITAE Suresh B. Boppana, M.D. University of … · 2019-05-21 · Suresh B. Boppana Page 4 . NIH • October 2017, NIDCD Institutional Research Training Grant Review (ZDC1